| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | GPI anchor binding | 3.58e-10 | 23 | 157 | 7 | GO:0034235 | |
| GeneOntologyMolecularFunction | glycolipid binding | 1.06e-07 | 49 | 157 | 7 | GO:0051861 | |
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 4.08e-07 | 37 | 157 | 6 | GO:0004190 | |
| GeneOntologyMolecularFunction | alpha2-adrenergic receptor activity | 4.77e-07 | 3 | 157 | 3 | GO:0004938 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 4.81e-07 | 38 | 157 | 6 | GO:0070001 | |
| GeneOntologyMolecularFunction | peptidase activity | DPEP1 USP18 ADAM15 ACR ERVK-7 ERVK-21 ERVK-9 PGC F12 MST1 MMEL1 DPEP2 FURIN ERVK-18 PAPPA MST1L ERVK-24 AGBL2 YME1L1 | 9.73e-07 | 654 | 157 | 19 | GO:0008233 |
| GeneOntologyMolecularFunction | hydrolase activity, hydrolyzing O-glycosyl compounds | 1.54e-06 | 103 | 157 | 8 | GO:0004553 | |
| GeneOntologyMolecularFunction | endopeptidase activity | ADAM15 ACR ERVK-7 ERVK-21 ERVK-9 PGC F12 MST1 MMEL1 FURIN ERVK-18 PAPPA MST1L ERVK-24 YME1L1 | 1.60e-06 | 430 | 157 | 15 | GO:0004175 |
| GeneOntologyMolecularFunction | RNA polymerase II sequence-specific DNA-binding transcription factor recruiting activity | 1.90e-06 | 4 | 157 | 3 | GO:0001010 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on glycosyl bonds | 2.10e-06 | 144 | 157 | 9 | GO:0016798 | |
| GeneOntologyMolecularFunction | granulocyte colony-stimulating factor receptor binding | 3.46e-06 | 14 | 157 | 4 | GO:0005130 | |
| GeneOntologyMolecularFunction | carbohydrate binding | SIGLEC12 MGAM LAYN MAN2B1 CHODL ACR CHI3L2 CLEC4D CRYBG3 PLOD2 ADGRL3 CLEC2B | 6.49e-06 | 310 | 157 | 12 | GO:0030246 |
| GeneOntologyMolecularFunction | bile acid transmembrane transporter activity | 6.52e-06 | 34 | 157 | 5 | GO:0015125 | |
| GeneOntologyMolecularFunction | epinephrine binding | 9.37e-06 | 6 | 157 | 3 | GO:0051379 | |
| GeneOntologyMolecularFunction | amylase activity | 9.37e-06 | 6 | 157 | 3 | GO:0016160 | |
| GeneOntologyMolecularFunction | alpha-adrenergic receptor activity | 9.37e-06 | 6 | 157 | 3 | GO:0004936 | |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 2.37e-05 | 73 | 157 | 6 | GO:0170055 | |
| GeneOntologyMolecularFunction | adrenergic receptor activity | 5.50e-05 | 10 | 157 | 3 | GO:0004935 | |
| GeneOntologyMolecularFunction | filamin binding | 7.49e-05 | 29 | 157 | 4 | GO:0031005 | |
| GeneOntologyMolecularFunction | Toll-like receptor binding | 7.49e-05 | 29 | 157 | 4 | GO:0035325 | |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 7.76e-05 | 90 | 157 | 6 | GO:0008028 | |
| GeneOntologyMolecularFunction | catecholamine binding | 1.29e-04 | 13 | 157 | 3 | GO:1901338 | |
| GeneOntologyMolecularFunction | hormone binding | 1.64e-04 | 103 | 157 | 6 | GO:0042562 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 1.64e-04 | 196 | 157 | 8 | GO:0005319 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase binding | 1.79e-04 | 149 | 157 | 7 | GO:1990782 | |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 2.26e-04 | 70 | 157 | 5 | GO:1901618 | |
| GeneOntologyMolecularFunction | mechanosensitive monoatomic ion channel activity | 3.57e-04 | 18 | 157 | 3 | GO:0008381 | |
| GeneOntologyMolecularFunction | low-affinity IgG receptor activity | 3.65e-04 | 4 | 157 | 2 | GO:0019772 | |
| GeneOntologyMolecularFunction | alpha-amylase activity | 6.05e-04 | 5 | 157 | 2 | GO:0004556 | |
| GeneOntologyMolecularFunction | chitinase activity | 9.03e-04 | 6 | 157 | 2 | GO:0004568 | |
| GeneOntologyMolecularFunction | IgE receptor activity | 9.03e-04 | 6 | 157 | 2 | GO:0019767 | |
| GeneOntologyMolecularFunction | collagen receptor activity | 9.03e-04 | 6 | 157 | 2 | GO:0038064 | |
| GeneOntologyMolecularFunction | monosaccharide binding | 9.25e-04 | 95 | 157 | 5 | GO:0048029 | |
| GeneOntologyMolecularFunction | metallopeptidase activity | 1.05e-03 | 200 | 157 | 7 | GO:0008237 | |
| GeneOntologyMolecularFunction | transporter activity | SLC6A18 ATP8B3 CEACAM5 PSG2 PSG11 TRPC5 CEACAM6 APOB SLC44A4 PKDREJ TMC3 CHRNB1 CHRNG TFRC SLCO1B7 PIEZO2 P2RX6 TMC8 ABCD4 LRP2 NIPAL1 | 1.19e-03 | 1289 | 157 | 21 | GO:0005215 |
| GeneOntologyMolecularFunction | D-mannose binding | 1.21e-03 | 27 | 157 | 3 | GO:0005537 | |
| GeneOntologyMolecularFunction | IgE binding | 1.26e-03 | 7 | 157 | 2 | GO:0019863 | |
| GeneOntologyMolecularFunction | IgG receptor activity | 1.26e-03 | 7 | 157 | 2 | GO:0019770 | |
| GeneOntologyMolecularFunction | lysine-acetylated histone binding | 1.66e-03 | 30 | 157 | 3 | GO:0070577 | |
| GeneOntologyMolecularFunction | chitin binding | 1.67e-03 | 8 | 157 | 2 | GO:0008061 | |
| GeneOntologyMolecularFunction | acetylation-dependent protein binding | 1.82e-03 | 31 | 157 | 3 | GO:0140033 | |
| GeneOntologyMolecularFunction | metallodipeptidase activity | 2.65e-03 | 10 | 157 | 2 | GO:0070573 | |
| GeneOntologyMolecularFunction | IgG binding | 3.22e-03 | 11 | 157 | 2 | GO:0019864 | |
| GeneOntologyMolecularFunction | phosphatidylinositol binding | 3.60e-03 | 316 | 157 | 8 | GO:0035091 | |
| GeneOntologyMolecularFunction | complement component C3b binding | 3.85e-03 | 12 | 157 | 2 | GO:0001851 | |
| GeneOntologyMolecularFunction | G protein-coupled amine receptor activity | 4.08e-03 | 41 | 157 | 3 | GO:0008227 | |
| GeneOntologyBiologicalProcess | regulation of tissue remodeling | CEACAM5 PSG2 PSG11 DDR2 CEACAM6 TFRC CSF1R FCGR3A FCGR3B CST3 | 4.56e-08 | 128 | 155 | 10 | GO:0034103 |
| GeneOntologyBiologicalProcess | regulation of bone resorption | 5.40e-08 | 70 | 155 | 8 | GO:0045124 | |
| GeneOntologyBiologicalProcess | regulation of bone remodeling | 1.56e-07 | 80 | 155 | 8 | GO:0046850 | |
| GeneOntologyBiologicalProcess | regulation of stem cell division | 1.78e-07 | 18 | 155 | 5 | GO:2000035 | |
| GeneOntologyBiologicalProcess | negative regulation of epinephrine secretion | 6.22e-07 | 10 | 155 | 4 | GO:0032811 | |
| GeneOntologyBiologicalProcess | bone resorption | 8.14e-07 | 99 | 155 | 8 | GO:0045453 | |
| GeneOntologyBiologicalProcess | negative regulation of norepinephrine secretion | 9.72e-07 | 11 | 155 | 4 | GO:0010700 | |
| GeneOntologyBiologicalProcess | regulation of epinephrine secretion | 9.72e-07 | 11 | 155 | 4 | GO:0014060 | |
| GeneOntologyBiologicalProcess | common myeloid progenitor cell proliferation | 1.06e-06 | 25 | 155 | 5 | GO:0035726 | |
| GeneOntologyBiologicalProcess | receptor transactivation | 1.66e-06 | 4 | 155 | 3 | GO:0035624 | |
| GeneOntologyBiologicalProcess | negative regulation of endodermal cell fate specification | 1.66e-06 | 4 | 155 | 3 | GO:0042664 | |
| GeneOntologyBiologicalProcess | stem cell division | 1.75e-06 | 49 | 155 | 6 | GO:0017145 | |
| GeneOntologyBiologicalProcess | epinephrine secretion | 2.08e-06 | 13 | 155 | 4 | GO:0048242 | |
| GeneOntologyBiologicalProcess | negative regulation of brown fat cell proliferation | 2.90e-06 | 14 | 155 | 4 | GO:0070348 | |
| GeneOntologyBiologicalProcess | regulation of blood vessel remodeling | 3.84e-06 | 32 | 155 | 5 | GO:0060312 | |
| GeneOntologyBiologicalProcess | regulation of brown fat cell proliferation | 3.93e-06 | 15 | 155 | 4 | GO:0070347 | |
| GeneOntologyBiologicalProcess | positive regulation of homophilic cell adhesion | 3.93e-06 | 15 | 155 | 4 | GO:1903387 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immune response to tumor cell | 3.93e-06 | 15 | 155 | 4 | GO:0002856 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 3.93e-06 | 15 | 155 | 4 | GO:0002859 | |
| GeneOntologyBiologicalProcess | regulation of endodermal cell fate specification | 4.12e-06 | 5 | 155 | 3 | GO:0042663 | |
| GeneOntologyBiologicalProcess | negative regulation of feeding behavior | 4.50e-06 | 33 | 155 | 5 | GO:2000252 | |
| GeneOntologyBiologicalProcess | insulin receptor internalization | 5.20e-06 | 16 | 155 | 4 | GO:0038016 | |
| GeneOntologyBiologicalProcess | bone remodeling | 5.34e-06 | 127 | 155 | 8 | GO:0046849 | |
| GeneOntologyBiologicalProcess | brown fat cell proliferation | 6.77e-06 | 17 | 155 | 4 | GO:0070342 | |
| GeneOntologyBiologicalProcess | insulin catabolic process | 6.77e-06 | 17 | 155 | 4 | GO:1901143 | |
| GeneOntologyBiologicalProcess | epinephrine transport | 6.77e-06 | 17 | 155 | 4 | GO:0048241 | |
| GeneOntologyBiologicalProcess | granulocyte colony-stimulating factor signaling pathway | 6.77e-06 | 17 | 155 | 4 | GO:0038158 | |
| GeneOntologyBiologicalProcess | negative regulation of endodermal cell differentiation | 8.19e-06 | 6 | 155 | 3 | GO:1903225 | |
| GeneOntologyBiologicalProcess | gland morphogenesis | 8.27e-06 | 178 | 155 | 9 | GO:0022612 | |
| GeneOntologyBiologicalProcess | regulation of homophilic cell adhesion | 8.65e-06 | 18 | 155 | 4 | GO:1903385 | |
| GeneOntologyBiologicalProcess | negative regulation of hepatocyte proliferation | 1.35e-05 | 20 | 155 | 4 | GO:2000346 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity | 1.45e-05 | 105 | 155 | 7 | GO:0042267 | |
| GeneOntologyBiologicalProcess | negative regulation of fat cell proliferation | 1.66e-05 | 21 | 155 | 4 | GO:0070345 | |
| GeneOntologyBiologicalProcess | negative regulation of response to tumor cell | 1.66e-05 | 21 | 155 | 4 | GO:0002835 | |
| GeneOntologyBiologicalProcess | negative regulation of immune response to tumor cell | 1.66e-05 | 21 | 155 | 4 | GO:0002838 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated immunity | 1.85e-05 | 109 | 155 | 7 | GO:0002228 | |
| GeneOntologyBiologicalProcess | negative regulation of response to biotic stimulus | 1.90e-05 | 151 | 155 | 8 | GO:0002832 | |
| GeneOntologyBiologicalProcess | negative regulation of granulocyte differentiation | 2.02e-05 | 22 | 155 | 4 | GO:0030853 | |
| GeneOntologyBiologicalProcess | negative regulation of behavior | 2.15e-05 | 45 | 155 | 5 | GO:0048521 | |
| GeneOntologyBiologicalProcess | negative regulation of cell fate specification | 2.27e-05 | 8 | 155 | 3 | GO:0009996 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet aggregation | 2.43e-05 | 23 | 155 | 4 | GO:0090331 | |
| GeneOntologyBiologicalProcess | negative regulation of catecholamine secretion | 2.43e-05 | 23 | 155 | 4 | GO:0033604 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 2.43e-05 | 23 | 155 | 4 | GO:0002858 | |
| GeneOntologyBiologicalProcess | negative regulation of innate immune response | 2.48e-05 | 114 | 155 | 7 | GO:0045824 | |
| GeneOntologyBiologicalProcess | bile acid and bile salt transport | 2.67e-05 | 47 | 155 | 5 | GO:0015721 | |
| GeneOntologyBiologicalProcess | negative regulation of tissue remodeling | 2.67e-05 | 47 | 155 | 5 | GO:0034104 | |
| GeneOntologyBiologicalProcess | positive regulation of cell population proliferation | MPL NANOGP8 NOG AVPR2 NANOG TRPC5 DDR2 CEACAM6 CR1 TFRC SIRPG MST1 KMT2C ADRA2A CSF1R NANOGP1 SCUBE2 FCGR3A CST3 LRP2 POLD4 MST1L TSLP | 2.85e-05 | 1190 | 155 | 23 | GO:0008284 |
| GeneOntologyBiologicalProcess | positive regulation of vasculogenesis | 2.90e-05 | 24 | 155 | 4 | GO:2001214 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immune response to tumor cell | 2.90e-05 | 24 | 155 | 4 | GO:0002855 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity directed against tumor cell target | 2.90e-05 | 24 | 155 | 4 | GO:0002420 | |
| GeneOntologyBiologicalProcess | tissue remodeling | CEACAM5 PSG2 PSG11 DDR2 CEACAM6 TFRC CSF1R FCGR3A FCGR3B CST3 | 3.01e-05 | 262 | 155 | 10 | GO:0048771 |
| GeneOntologyBiologicalProcess | natural killer cell mediated immune response to tumor cell | 3.43e-05 | 25 | 155 | 4 | GO:0002423 | |
| GeneOntologyBiologicalProcess | hemostasis | CEACAM5 PSG2 AVPR2 PSG11 CEACAM6 LYST F12 ADRA2A ADRA2B ADRA2C | 3.65e-05 | 268 | 155 | 10 | GO:0007599 |
| GeneOntologyBiologicalProcess | regulation of norepinephrine secretion | 4.03e-05 | 26 | 155 | 4 | GO:0014061 | |
| GeneOntologyBiologicalProcess | negative regulation of cell killing | 4.39e-05 | 52 | 155 | 5 | GO:0031342 | |
| GeneOntologyBiologicalProcess | regulation of fat cell proliferation | 4.71e-05 | 27 | 155 | 4 | GO:0070344 | |
| GeneOntologyBiologicalProcess | regulation of endodermal cell differentiation | 4.81e-05 | 10 | 155 | 3 | GO:1903224 | |
| GeneOntologyBiologicalProcess | norepinephrine secretion | 5.46e-05 | 28 | 155 | 4 | GO:0048243 | |
| GeneOntologyBiologicalProcess | negative regulation of homotypic cell-cell adhesion | 5.46e-05 | 28 | 155 | 4 | GO:0034111 | |
| GeneOntologyBiologicalProcess | perforin production | 5.61e-05 | 2 | 155 | 2 | GO:0035944 | |
| GeneOntologyBiologicalProcess | negative regulation of uterine smooth muscle contraction | 5.61e-05 | 2 | 155 | 2 | GO:0070473 | |
| GeneOntologyBiologicalProcess | leukotriene D4 catabolic process | 5.61e-05 | 2 | 155 | 2 | GO:1901749 | |
| GeneOntologyBiologicalProcess | regulation of vasculogenesis | 6.29e-05 | 29 | 155 | 4 | GO:2001212 | |
| GeneOntologyBiologicalProcess | immune response to tumor cell | 6.30e-05 | 56 | 155 | 5 | GO:0002418 | |
| GeneOntologyBiologicalProcess | endodermal cell fate specification | 6.57e-05 | 11 | 155 | 3 | GO:0001714 | |
| GeneOntologyBiologicalProcess | negative regulation of defense response | SIGLEC12 USP18 CEACAM5 PSG2 PSG11 VSIG4 CEACAM6 CR1 SIRPG FURIN MAPKBP1 | 7.61e-05 | 353 | 155 | 11 | GO:0031348 |
| GeneOntologyBiologicalProcess | multi-multicellular organism process | 7.91e-05 | 294 | 155 | 10 | GO:0044706 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet activation | 8.24e-05 | 31 | 155 | 4 | GO:0010544 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound transport | CEACAM5 PSG2 PSG11 CEACAM6 APOB CRHR2 SLCO1B7 ADRA2A ADRA2B ADRA2C FURIN | 8.62e-05 | 358 | 155 | 11 | GO:0015850 |
| GeneOntologyBiologicalProcess | leukocyte mediated cytotoxicity | 8.69e-05 | 187 | 155 | 8 | GO:0001909 | |
| GeneOntologyBiologicalProcess | regulation of uterine smooth muscle contraction | 8.71e-05 | 12 | 155 | 3 | GO:0070472 | |
| GeneOntologyBiologicalProcess | negative regulation of bone resorption | 9.36e-05 | 32 | 155 | 4 | GO:0045779 | |
| GeneOntologyBiologicalProcess | fat cell proliferation | 9.36e-05 | 32 | 155 | 4 | GO:0070341 | |
| GeneOntologyBiologicalProcess | regulation of feeding behavior | 9.52e-05 | 61 | 155 | 5 | GO:0060259 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte proliferation | 9.61e-05 | 301 | 155 | 10 | GO:0050670 | |
| GeneOntologyBiologicalProcess | regulation of granulocyte differentiation | 1.06e-04 | 33 | 155 | 4 | GO:0030852 | |
| GeneOntologyBiologicalProcess | regulation of mononuclear cell proliferation | 1.10e-04 | 306 | 155 | 10 | GO:0032944 | |
| GeneOntologyBiologicalProcess | uterine smooth muscle contraction | 1.13e-04 | 13 | 155 | 3 | GO:0070471 | |
| GeneOntologyBiologicalProcess | cell killing | 1.13e-04 | 307 | 155 | 10 | GO:0001906 | |
| GeneOntologyBiologicalProcess | female pregnancy | 1.15e-04 | 249 | 155 | 9 | GO:0007565 | |
| GeneOntologyBiologicalProcess | negative regulation of vascular permeability | 1.19e-04 | 34 | 155 | 4 | GO:0043116 | |
| GeneOntologyBiologicalProcess | negative regulation of bone remodeling | 1.19e-04 | 34 | 155 | 4 | GO:0046851 | |
| GeneOntologyBiologicalProcess | insulin metabolic process | 1.34e-04 | 35 | 155 | 4 | GO:1901142 | |
| GeneOntologyBiologicalProcess | negative regulation of T cell proliferation | 1.58e-04 | 107 | 155 | 6 | GO:0042130 | |
| GeneOntologyBiologicalProcess | blood coagulation | 1.59e-04 | 260 | 155 | 9 | GO:0007596 | |
| GeneOntologyBiologicalProcess | regulation of platelet formation | 1.67e-04 | 3 | 155 | 2 | GO:1905219 | |
| GeneOntologyBiologicalProcess | negative regulation of complement activation, alternative pathway | 1.67e-04 | 3 | 155 | 2 | GO:0045957 | |
| GeneOntologyBiologicalProcess | negative regulation of blood coagulation | 1.71e-04 | 69 | 155 | 5 | GO:0030195 | |
| GeneOntologyBiologicalProcess | cell dedifferentiation | 1.77e-04 | 15 | 155 | 3 | GO:0043697 | |
| GeneOntologyBiologicalProcess | dedifferentiation | 1.77e-04 | 15 | 155 | 3 | GO:0043696 | |
| GeneOntologyBiologicalProcess | negative regulation of hemostasis | 1.83e-04 | 70 | 155 | 5 | GO:1900047 | |
| GeneOntologyBiologicalProcess | norepinephrine transport | 1.86e-04 | 38 | 155 | 4 | GO:0015874 | |
| GeneOntologyBiologicalProcess | regulation of hepatocyte proliferation | 1.86e-04 | 38 | 155 | 4 | GO:2000345 | |
| GeneOntologyBiologicalProcess | coagulation | 1.88e-04 | 266 | 155 | 9 | GO:0050817 | |
| GeneOntologyBiologicalProcess | platelet activation | 1.95e-04 | 158 | 155 | 7 | GO:0030168 | |
| GeneOntologyBiologicalProcess | response to tumor cell | 1.96e-04 | 71 | 155 | 5 | GO:0002347 | |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid biosynthetic process | 2.06e-04 | 39 | 155 | 4 | GO:0045717 | |
| GeneOntologyBiologicalProcess | negative regulation of coagulation | 2.10e-04 | 72 | 155 | 5 | GO:0050819 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte proliferation | 2.13e-04 | 332 | 155 | 10 | GO:0070663 | |
| GeneOntologyBiologicalProcess | oligosaccharide catabolic process | 2.17e-04 | 16 | 155 | 3 | GO:0009313 | |
| GeneOntologyCellularComponent | cell surface | MPL SIGLEC12 ITGA11 CEACAM5 LAYN SEMA7A PSG2 ADAM15 PSG11 CEACAM6 CR1 RS1 TFRC SIRPG LY6G5B ADRA2B CSF1R SCUBE2 FCGR3A CLEC4D FCGR3B FURIN ADGRE4P LRP2 CLEC2B IGSF3 | 3.84e-07 | 1111 | 161 | 26 | GO:0009986 |
| GeneOntologyCellularComponent | external side of plasma membrane | MPL SIGLEC12 ITGA11 CEACAM5 SEMA7A PSG2 PSG11 CEACAM6 CR1 RS1 TFRC LY6G5B FCGR3A CLEC4D FCGR3B LRP2 CLEC2B | 5.68e-07 | 519 | 161 | 17 | GO:0009897 |
| GeneOntologyCellularComponent | receptor complex | ITGA11 CEACAM5 PSG2 PSG11 DDR2 CEACAM6 CR1 CHRNB1 CHRNG TFRC SHISA9 ADRA2A CSF1R P2RX6 TAS1R2 LRP2 PLP1 | 2.64e-06 | 581 | 161 | 17 | GO:0043235 |
| GeneOntologyCellularComponent | transforming growth factor beta ligand-receptor complex | 5.74e-06 | 16 | 161 | 4 | GO:0070021 | |
| GeneOntologyCellularComponent | side of membrane | MPL SIGLEC12 DPEP1 ITGA11 CEACAM5 SEMA7A PSG2 PSG11 CEACAM6 CR1 RS1 TFRC LY6G5B FCGR3A CLEC4D FCGR3B DPEP2 LRP2 CNTN3 CLEC2B | 1.37e-05 | 875 | 161 | 20 | GO:0098552 |
| GeneOntologyCellularComponent | Fc-gamma receptor III complex | 3.50e-04 | 4 | 161 | 2 | GO:0033001 | |
| GeneOntologyCellularComponent | plasma membrane signaling receptor complex | ITGA11 CEACAM5 PSG2 PSG11 CEACAM6 CHRNB1 CHRNG TFRC SHISA9 PLP1 | 3.96e-04 | 350 | 161 | 10 | GO:0098802 |
| GeneOntologyCellularComponent | basolateral plasma membrane | 8.63e-04 | 320 | 161 | 9 | GO:0016323 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | ITGA11 CEACAM5 PSG2 PSG11 CEACAM6 SSPOP CHRNB1 CHRNG TFRC SHISA9 FCGR3A FCGR3B ABCD4 C7 PLP1 | 1.12e-03 | 785 | 161 | 15 | GO:0098797 |
| GeneOntologyCellularComponent | apical plasma membrane | SLC6A18 DPEP1 MGAM CEACAM5 PSG2 PSG11 DDR2 CEACAM6 SLC44A4 LRP2 OTOG | 1.42e-03 | 487 | 161 | 11 | GO:0016324 |
| MousePheno | decreased susceptibility to Coronaviridae infection | 5.13e-06 | 28 | 129 | 5 | MP:0020950 | |
| MousePheno | decreased susceptibility to Coronaviridae infection induced morbidity/mortality | 1.50e-05 | 17 | 129 | 4 | MP:0031047 | |
| MousePheno | increased skeletal muscle triglyceride level | 3.67e-05 | 21 | 129 | 4 | MP:0031415 | |
| MousePheno | abnormal renal tubule morphology | 4.77e-05 | 227 | 129 | 10 | MP:0002703 | |
| MousePheno | absent primitive endoderm | 6.19e-05 | 9 | 129 | 3 | MP:0011185 | |
| MousePheno | decreased fatty acid oxidation | 6.37e-05 | 24 | 129 | 4 | MP:0014172 | |
| MousePheno | abnormal susceptibility to Coronaviridae infection | 8.53e-05 | 49 | 129 | 5 | MP:0020948 | |
| MousePheno | increased abdominal fat pad weight | 1.03e-04 | 27 | 129 | 4 | MP:0009286 | |
| MousePheno | decreased susceptibility to Riboviria infection | 1.08e-04 | 82 | 129 | 6 | MP:0020914 | |
| MousePheno | abnormal skeletal muscle triglyceride level | 1.80e-04 | 31 | 129 | 4 | MP:0031413 | |
| MousePheno | decreased carbon dioxide production | 1.80e-04 | 31 | 129 | 4 | MP:0008964 | |
| Domain | Ig_2 | 1.37e-07 | 73 | 152 | 8 | PF13895 | |
| Domain | V-set | SIGLEC12 CEACAM5 PSG2 PSG11 VSIG4 CEACAM6 SIRPG CSF1R CNTN3 KIRREL1 IGSF3 | 3.26e-07 | 184 | 152 | 11 | PF07686 |
| Domain | ig | SIGLEC12 CEACAM5 PSG2 PSG11 VSIG4 CEACAM6 SIRPG CSF1R FCGR3A FCGR3B CNTN3 | 4.50e-07 | 190 | 152 | 11 | PF00047 |
| Domain | Immunoglobulin | SIGLEC12 CEACAM5 PSG2 PSG11 VSIG4 CEACAM6 SIRPG CSF1R FCGR3A FCGR3B CNTN3 | 4.50e-07 | 190 | 152 | 11 | IPR013151 |
| Domain | Ig_V-set | SIGLEC12 CEACAM5 PSG2 PSG11 VSIG4 CEACAM6 SIRPG CSF1R CNTN3 KIRREL1 IGSF3 | 7.13e-07 | 199 | 152 | 11 | IPR013106 |
| Domain | IG | SIGLEC12 CEACAM5 SEMA7A PSG2 PSG11 VSIG4 CEACAM6 SIRPG CSF1R FCGR3A FCGR3B CEACAM16 CNTN3 KIRREL1 IGSF3 | 1.85e-06 | 421 | 152 | 15 | SM00409 |
| Domain | Ig_sub | SIGLEC12 CEACAM5 SEMA7A PSG2 PSG11 VSIG4 CEACAM6 SIRPG CSF1R FCGR3A FCGR3B CEACAM16 CNTN3 KIRREL1 IGSF3 | 1.85e-06 | 421 | 152 | 15 | IPR003599 |
| Domain | - | MPL SIGLEC12 CEACAM5 SEMA7A MYCBP2 PSG2 PSG11 VSIG4 CEACAM6 PKHD1L1 SIRPG CSF1R FCGR3A FCGR3B CEACAM16 CNTN3 KIRREL1 CAMTA1 IGSF3 | 1.93e-06 | 663 | 152 | 19 | 2.60.40.10 |
| Domain | IGc2 | SIGLEC12 CEACAM5 PSG2 PSG11 VSIG4 CEACAM6 CSF1R CEACAM16 CNTN3 KIRREL1 IGSF3 | 3.61e-06 | 235 | 152 | 11 | SM00408 |
| Domain | Ig_sub2 | SIGLEC12 CEACAM5 PSG2 PSG11 VSIG4 CEACAM6 CSF1R CEACAM16 CNTN3 KIRREL1 IGSF3 | 3.61e-06 | 235 | 152 | 11 | IPR003598 |
| Domain | Glycoside_hydrolase_SF | 4.41e-06 | 53 | 152 | 6 | IPR017853 | |
| Domain | Ig-like_fold | MPL SIGLEC12 CEACAM5 SEMA7A MYCBP2 PSG2 PSG11 VSIG4 CEACAM6 PKHD1L1 SIRPG CSF1R FCGR3A FCGR3B CEACAM16 CNTN3 KIRREL1 CAMTA1 IGSF3 | 4.80e-06 | 706 | 152 | 19 | IPR013783 |
| Domain | IG_LIKE | SIGLEC12 CEACAM5 SEMA7A PSG2 PSG11 VSIG4 CEACAM6 SIRPG CSF1R FCGR3A FCGR3B CEACAM16 CNTN3 KIRREL1 IGSF3 | 1.18e-05 | 491 | 152 | 15 | PS50835 |
| Domain | Glyco_hydro_catalytic_dom | 1.35e-05 | 38 | 152 | 5 | IPR013781 | |
| Domain | Ig-like_dom | SIGLEC12 CEACAM5 SEMA7A PSG2 PSG11 VSIG4 CEACAM6 SIRPG CSF1R FCGR3A FCGR3B CEACAM16 CNTN3 KIRREL1 IGSF3 | 1.57e-05 | 503 | 152 | 15 | IPR007110 |
| Domain | ADR_fam | 6.08e-05 | 10 | 152 | 3 | IPR002233 | |
| Domain | Med13_N | 6.58e-05 | 2 | 152 | 2 | PF11597 | |
| Domain | Mediator_Med13_N_met/fun | 6.58e-05 | 2 | 152 | 2 | IPR021643 | |
| Domain | Med13_C | 6.58e-05 | 2 | 152 | 2 | PF06333 | |
| Domain | Mediator_Med13 | 6.58e-05 | 2 | 152 | 2 | IPR009401 | |
| Domain | EGF_3 | 1.34e-04 | 235 | 152 | 9 | PS50026 | |
| Domain | TIL_dom | 1.80e-04 | 14 | 152 | 3 | IPR002919 | |
| Domain | - | 1.80e-04 | 14 | 152 | 3 | 2.60.40.1180 | |
| Domain | - | 1.81e-04 | 35 | 152 | 4 | 3.20.20.80 | |
| Domain | Renal_dipep_fam | 1.96e-04 | 3 | 152 | 2 | IPR008257 | |
| Domain | Peptidase_M19 | 1.96e-04 | 3 | 152 | 2 | PF01244 | |
| Domain | Dipep_AS | 1.96e-04 | 3 | 152 | 2 | IPR000180 | |
| Domain | RENAL_DIPEPTIDASE_1 | 1.96e-04 | 3 | 152 | 2 | PS00869 | |
| Domain | A-amylase_C | 1.96e-04 | 3 | 152 | 2 | IPR031319 | |
| Domain | RENAL_DIPEPTIDASE_2 | 1.96e-04 | 3 | 152 | 2 | PS51365 | |
| Domain | Glyco_hydro_b | 2.24e-04 | 15 | 152 | 3 | IPR013780 | |
| Domain | LDLR_class-A_CS | 3.07e-04 | 40 | 152 | 4 | IPR023415 | |
| Domain | - | 3.22e-04 | 73 | 152 | 5 | 2.60.120.260 | |
| Domain | Kringle_CS | 3.30e-04 | 17 | 152 | 3 | IPR018056 | |
| Domain | KRINGLE_1 | 3.30e-04 | 17 | 152 | 3 | PS00021 | |
| Domain | KR | 3.30e-04 | 17 | 152 | 3 | SM00130 | |
| Domain | Kringle | 3.30e-04 | 17 | 152 | 3 | IPR000001 | |
| Domain | KRINGLE_2 | 3.30e-04 | 17 | 152 | 3 | PS50070 | |
| Domain | Kringle | 3.30e-04 | 17 | 152 | 3 | PF00051 | |
| Domain | Alpha_amylase | 3.91e-04 | 4 | 152 | 2 | IPR006046 | |
| Domain | Aamy_C | 3.91e-04 | 4 | 152 | 2 | SM00632 | |
| Domain | Ldl_recept_a | 4.85e-04 | 45 | 152 | 4 | PF00057 | |
| Domain | - | 5.27e-04 | 46 | 152 | 4 | 4.10.400.10 | |
| Domain | LDLRA_1 | 6.21e-04 | 48 | 152 | 4 | PS01209 | |
| Domain | FA58C | 6.31e-04 | 21 | 152 | 3 | SM00231 | |
| Domain | FA58C_3 | 6.31e-04 | 21 | 152 | 3 | PS50022 | |
| Domain | FA58C_1 | 6.31e-04 | 21 | 152 | 3 | PS01285 | |
| Domain | FA58C_2 | 6.31e-04 | 21 | 152 | 3 | PS01286 | |
| Domain | Alpha-amylase_C | 6.47e-04 | 5 | 152 | 2 | PF02806 | |
| Domain | A-amylase/branching_C | 6.47e-04 | 5 | 152 | 2 | IPR006048 | |
| Domain | PAN_AP | 6.47e-04 | 5 | 152 | 2 | SM00473 | |
| Domain | LDrepeatLR_classA_rpt | 6.72e-04 | 49 | 152 | 4 | IPR002172 | |
| Domain | LDLa | 6.72e-04 | 49 | 152 | 4 | SM00192 | |
| Domain | LDLRA_2 | 6.72e-04 | 49 | 152 | 4 | PS50068 | |
| Domain | 7tm_2 | 7.26e-04 | 50 | 152 | 4 | PF00002 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 7.26e-04 | 50 | 152 | 4 | PS00650 | |
| Domain | Sushi | 8.43e-04 | 52 | 152 | 4 | PF00084 | |
| Domain | F5_F8_type_C | 9.43e-04 | 24 | 152 | 3 | PF00754 | |
| Domain | FA58C | 9.43e-04 | 24 | 152 | 3 | IPR000421 | |
| Domain | Ig_I-set | 9.45e-04 | 190 | 152 | 7 | IPR013098 | |
| Domain | I-set | 9.45e-04 | 190 | 152 | 7 | PF07679 | |
| Domain | Glyco_hydro_18_chit_AS | 9.66e-04 | 6 | 152 | 2 | IPR001579 | |
| Domain | Glyco_hydro_13 | 9.66e-04 | 6 | 152 | 2 | IPR015902 | |
| Domain | CCP | 9.72e-04 | 54 | 152 | 4 | SM00032 | |
| Domain | EGF-like_dom | 1.01e-03 | 249 | 152 | 8 | IPR000742 | |
| Domain | Galactose-bd-like | 1.03e-03 | 94 | 152 | 5 | IPR008979 | |
| Domain | HormR | 1.07e-03 | 25 | 152 | 3 | SM00008 | |
| Domain | SUSHI | 1.11e-03 | 56 | 152 | 4 | PS50923 | |
| Domain | Sushi_SCR_CCP_dom | 1.19e-03 | 57 | 152 | 4 | IPR000436 | |
| Domain | Glyco_hydro18_cat | 1.35e-03 | 7 | 152 | 2 | IPR001223 | |
| Domain | Pan_app | 1.35e-03 | 7 | 152 | 2 | IPR003609 | |
| Domain | Glyco_hydro_13_cat_dom | 1.35e-03 | 7 | 152 | 2 | IPR006047 | |
| Domain | TLV_coat | 1.35e-03 | 7 | 152 | 2 | PF00429 | |
| Domain | Alpha-amylase | 1.35e-03 | 7 | 152 | 2 | PF00128 | |
| Domain | PAN | 1.35e-03 | 7 | 152 | 2 | PS50948 | |
| Domain | Glyco_hydro_18 | 1.35e-03 | 7 | 152 | 2 | PF00704 | |
| Domain | Chitinase_II | 1.35e-03 | 7 | 152 | 2 | IPR011583 | |
| Domain | Aamy | 1.35e-03 | 7 | 152 | 2 | SM00642 | |
| Domain | Glyco_18 | 1.35e-03 | 7 | 152 | 2 | SM00636 | |
| Domain | CHITINASE_18 | 1.35e-03 | 7 | 152 | 2 | PS01095 | |
| Domain | PAN_1 | 1.35e-03 | 7 | 152 | 2 | PF00024 | |
| Domain | GPCR_2_secretin-like | 1.44e-03 | 60 | 152 | 4 | IPR000832 | |
| Domain | HRM | 1.49e-03 | 28 | 152 | 3 | PF02793 | |
| Domain | G_PROTEIN_RECEP_F2_4 | 1.54e-03 | 61 | 152 | 4 | PS50261 | |
| Domain | TMC | 1.78e-03 | 8 | 152 | 2 | PF07810 | |
| Domain | Carboxylesterase_B_AS | 1.78e-03 | 8 | 152 | 2 | IPR019826 | |
| Domain | TLV/ENV_coat_polyprotein | 1.78e-03 | 8 | 152 | 2 | IPR018154 | |
| Domain | CARBOXYLESTERASE_B_1 | 1.78e-03 | 8 | 152 | 2 | PS00122 | |
| Domain | TMC | 1.78e-03 | 8 | 152 | 2 | IPR012496 | |
| Domain | Kringle-like | 2.20e-03 | 32 | 152 | 3 | IPR013806 | |
| Domain | GPS | 2.63e-03 | 34 | 152 | 3 | SM00303 | |
| Domain | GPCR_2_secretin-like_CS | 2.63e-03 | 34 | 152 | 3 | IPR017983 | |
| Domain | MAC_perforin | 2.84e-03 | 10 | 152 | 2 | IPR001862 | |
| Domain | EGF | 3.16e-03 | 235 | 152 | 7 | SM00181 | |
| Domain | GPS | 3.35e-03 | 37 | 152 | 3 | IPR000203 | |
| Domain | MACPF | 3.45e-03 | 11 | 152 | 2 | PF01823 | |
| Domain | MACPF | 4.12e-03 | 12 | 152 | 2 | IPR020864 | |
| Domain | C8 | 4.12e-03 | 12 | 152 | 2 | PF08742 | |
| Domain | TIL | 4.12e-03 | 12 | 152 | 2 | PF01826 | |
| Domain | MACPF | 4.12e-03 | 12 | 152 | 2 | SM00457 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS | 1.13e-05 | 99 | 109 | 7 | MM14624 | |
| Pathway | REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE | 2.45e-05 | 8 | 109 | 3 | MM14717 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | ITGA11 CEACAM5 PSG2 ADAM15 PSG11 DDR2 CEACAM6 FURIN DMP1 PLOD2 | 3.08e-05 | 258 | 109 | 10 | MM14572 |
| Pathway | REACTOME_ADRENOCEPTORS | 3.65e-05 | 9 | 109 | 3 | M27302 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GLYCOGEN_DEGRADATION_AMYLASE_ | 3.65e-05 | 9 | 109 | 3 | M47622 | |
| Pathway | REACTOME_ADRENOCEPTORS | 3.65e-05 | 9 | 109 | 3 | MM15009 | |
| Pathway | REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE | 7.09e-05 | 11 | 109 | 3 | M1091 | |
| Pathway | WP_COMPLEMENT_SYSTEM | 9.81e-05 | 96 | 109 | 6 | M39581 | |
| Pathway | REACTOME_NEUTROPHIL_DEGRANULATION | SIGLEC12 MGAM CEACAM5 MAN2B1 PSG2 PSG11 CEACAM6 SIRPG FCGR3A CLEC4D FCGR3B CST3 CD68 | 1.56e-04 | 511 | 109 | 13 | MM15330 |
| Pathway | REACTOME_COBALAMIN_CBL_VITAMIN_B12_TRANSPORT_AND_METABOLISM | 1.91e-04 | 15 | 109 | 3 | MM14762 | |
| Pathway | REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION | 2.26e-04 | 39 | 109 | 4 | M10735 | |
| Pathway | WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE | 2.34e-04 | 16 | 109 | 3 | M39849 | |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | 2.57e-04 | 272 | 109 | 9 | M13380 | |
| Pathway | REACTOME_DIGESTION | 5.40e-04 | 21 | 109 | 3 | MM15526 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_ESPJ_TO_IGG_FCGR_RAC_SIGNALING_PATHWAY | 5.83e-04 | 5 | 109 | 2 | M49014 | |
| Pathway | REACTOME_COBALAMIN_CBL_VITAMIN_B12_TRANSPORT_AND_METABOLISM | 6.22e-04 | 22 | 109 | 3 | M27084 | |
| Pathway | REACTOME_DIGESTION | 7.12e-04 | 23 | 109 | 3 | M27790 | |
| Pathway | REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL | 7.66e-04 | 194 | 109 | 7 | M16312 | |
| Pathway | WP_GPCRS_CLASS_B_SECRETINLIKE | 8.09e-04 | 24 | 109 | 3 | MM15992 | |
| Pathway | WP_GPCRS_CLASS_B_SECRETINLIKE | 8.09e-04 | 24 | 109 | 3 | M39643 | |
| Pathway | REACTOME_SIGNALING_BY_MST1 | 8.71e-04 | 6 | 109 | 2 | MM15492 | |
| Pathway | REACTOME_DIGESTION_AND_ABSORPTION | 9.14e-04 | 25 | 109 | 3 | MM15557 | |
| Pathway | WP_GPCRS_NONODORANT | 1.06e-03 | 266 | 109 | 8 | MM15843 | |
| Pathway | BIOCARTA_MSP_PATHWAY | 1.21e-03 | 7 | 109 | 2 | MM1580 | |
| Pathway | REACTOME_TRANSPORT_OF_RCBL_WITHIN_THE_BODY | 1.21e-03 | 7 | 109 | 2 | MM15703 | |
| Pathway | REACTOME_LTC4_CYSLTR_MEDIATED_IL4_PRODUCTION | 1.21e-03 | 7 | 109 | 2 | M29845 | |
| Pathway | REACTOME_DIGESTION_AND_ABSORPTION | 1.28e-03 | 28 | 109 | 3 | M27837 | |
| Pathway | REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL | 1.41e-03 | 158 | 109 | 6 | MM14812 | |
| Pathway | REACTOME_INNATE_IMMUNE_SYSTEM | SIGLEC12 USP18 MGAM CEACAM5 MAN2B1 PSG2 PSG11 CEACAM6 APOB SIRPG FCGR3A CLEC4D FCGR3B LPO CST3 CD68 C7 | 1.59e-03 | 995 | 109 | 17 | MM14661 |
| Pathway | WP_PHASE_I_BIOTRANSFORMATIONS_NONP450 | 1.61e-03 | 8 | 109 | 2 | M39342 | |
| Pathway | WP_MIR302367_PROMOTING_CARDIOMYOCYTE_PROLIFERATION | 1.61e-03 | 8 | 109 | 2 | MM15986 | |
| Pathway | REACTOME_TRANSPORT_OF_RCBL_WITHIN_THE_BODY | 1.61e-03 | 8 | 109 | 2 | M45025 | |
| Pubmed | 6.42e-09 | 54 | 163 | 7 | 8482578 | ||
| Pubmed | 2.77e-08 | 39 | 163 | 6 | 1676977 | ||
| Pubmed | The pluripotency factor NANOG controls primitive hematopoiesis and directly regulates Tal1. | 1.01e-07 | 3 | 163 | 3 | 30814124 | |
| Pubmed | Multiple phases in regulation of Nanog expression during pre-implantation development. | 1.01e-07 | 3 | 163 | 3 | 26660234 | |
| Pubmed | Crystal structure and DNA binding of the homeodomain of the stem cell transcription factor Nanog. | 1.01e-07 | 3 | 163 | 3 | 18177668 | |
| Pubmed | 1.01e-07 | 3 | 163 | 3 | 24929238 | ||
| Pubmed | Nanog and transcriptional networks in embryonic stem cell pluripotency. | 1.01e-07 | 3 | 163 | 3 | 17211451 | |
| Pubmed | 1.01e-07 | 3 | 163 | 3 | 15502159 | ||
| Pubmed | 1.01e-07 | 3 | 163 | 3 | 20574542 | ||
| Pubmed | lincRNAs act in the circuitry controlling pluripotency and differentiation. | 1.01e-07 | 3 | 163 | 3 | 21874018 | |
| Pubmed | Cell signalling regulates dynamics of Nanog distribution in embryonic stem cell populations. | 1.01e-07 | 3 | 163 | 3 | 23054952 | |
| Pubmed | CrxOS maintains the self-renewal capacity of murine embryonic stem cells. | 1.01e-07 | 3 | 163 | 3 | 19800316 | |
| Pubmed | Selenium Augments microRNA Directed Reprogramming of Fibroblasts to Cardiomyocytes via Nanog. | 1.01e-07 | 3 | 163 | 3 | 26975336 | |
| Pubmed | Nanog suppresses cell migration by downregulating thymosin β4 and Rnd3. | 1.01e-07 | 3 | 163 | 3 | 23329853 | |
| Pubmed | 1.01e-07 | 3 | 163 | 3 | 9415717 | ||
| Pubmed | 1.01e-07 | 3 | 163 | 3 | 23665121 | ||
| Pubmed | Ectopic overexpression of Nanog induces tumorigenesis in non-tumorous fibroblasts. | 1.01e-07 | 3 | 163 | 3 | 26733157 | |
| Pubmed | 1.01e-07 | 3 | 163 | 3 | 17261653 | ||
| Pubmed | 1.01e-07 | 3 | 163 | 3 | 16501172 | ||
| Pubmed | Regulated fluctuations in nanog expression mediate cell fate decisions in embryonic stem cells. | 1.01e-07 | 3 | 163 | 3 | 19582141 | |
| Pubmed | 1.01e-07 | 3 | 163 | 3 | 19703398 | ||
| Pubmed | Nanog Fluctuations in Embryonic Stem Cells Highlight the Problem of Measurement in Cell Biology. | 1.01e-07 | 3 | 163 | 3 | 28636920 | |
| Pubmed | 1.01e-07 | 3 | 163 | 3 | 20539761 | ||
| Pubmed | 1.01e-07 | 3 | 163 | 3 | 18584034 | ||
| Pubmed | 1.01e-07 | 3 | 163 | 3 | 21969378 | ||
| Pubmed | 1.01e-07 | 3 | 163 | 3 | 20661723 | ||
| Pubmed | 1.01e-07 | 3 | 163 | 3 | 29245050 | ||
| Pubmed | Aggregation of embryonic stem cells induces Nanog repression and primitive endoderm differentiation. | 1.01e-07 | 3 | 163 | 3 | 15494369 | |
| Pubmed | Identification of two distinct transactivation domains in the pluripotency sustaining factor nanog. | 1.01e-07 | 3 | 163 | 3 | 14728807 | |
| Pubmed | Nanog overcomes reprogramming barriers and induces pluripotency in minimal conditions. | 1.01e-07 | 3 | 163 | 3 | 21194951 | |
| Pubmed | 1.01e-07 | 3 | 163 | 3 | 22388986 | ||
| Pubmed | 1.01e-07 | 3 | 163 | 3 | 16791199 | ||
| Pubmed | Heparan sulfate regulates self-renewal and pluripotency of embryonic stem cells. | 1.01e-07 | 3 | 163 | 3 | 18024963 | |
| Pubmed | 1.01e-07 | 3 | 163 | 3 | 27125671 | ||
| Pubmed | Regulation of alpha(2)-adrenoceptors in human vascular smooth muscle cells. | 1.01e-07 | 3 | 163 | 3 | 12946937 | |
| Pubmed | Stochastic promoter activation affects Nanog expression variability in mouse embryonic stem cells. | 1.01e-07 | 3 | 163 | 3 | 25410303 | |
| Pubmed | 1.01e-07 | 3 | 163 | 3 | 33334884 | ||
| Pubmed | 1.01e-07 | 3 | 163 | 3 | 20613626 | ||
| Pubmed | Forced expression of Nanog in hematopoietic stem cells results in a gammadeltaT-cell disorder. | 1.01e-07 | 3 | 163 | 3 | 17360937 | |
| Pubmed | 1.01e-07 | 3 | 163 | 3 | 19744502 | ||
| Pubmed | 1.01e-07 | 3 | 163 | 3 | 26760119 | ||
| Pubmed | 1.01e-07 | 3 | 163 | 3 | 27751959 | ||
| Pubmed | Nanog is dispensable for the generation of induced pluripotent stem cells. | 1.01e-07 | 3 | 163 | 3 | 24461999 | |
| Pubmed | Locating and Characterizing a Transgene Integration Site by Nanopore Sequencing. | 1.01e-07 | 3 | 163 | 3 | 30837263 | |
| Pubmed | 1.01e-07 | 3 | 163 | 3 | 25173648 | ||
| Pubmed | Distinct Contributions of Tryptophan Residues within the Dimerization Domain to Nanog Function. | 1.01e-07 | 3 | 163 | 3 | 27939294 | |
| Pubmed | 1.01e-07 | 3 | 163 | 3 | 18442017 | ||
| Pubmed | 1.01e-07 | 3 | 163 | 3 | 37841583 | ||
| Pubmed | 1.01e-07 | 3 | 163 | 3 | 11927164 | ||
| Pubmed | 1.01e-07 | 3 | 163 | 3 | 11125002 | ||
| Pubmed | 1.01e-07 | 3 | 163 | 3 | 12764077 | ||
| Pubmed | 1.01e-07 | 3 | 163 | 3 | 16790525 | ||
| Pubmed | Primitive endoderm differentiates via a three-step mechanism involving Nanog and RTK signaling. | 1.01e-07 | 3 | 163 | 3 | 22172669 | |
| Pubmed | 1.01e-07 | 3 | 163 | 3 | 19447925 | ||
| Pubmed | The molecular logic of Nanog-induced self-renewal in mouse embryonic stem cells. | 1.01e-07 | 3 | 163 | 3 | 30846691 | |
| Pubmed | Generation of germline-competent induced pluripotent stem cells. | 1.01e-07 | 3 | 163 | 3 | 17554338 | |
| Pubmed | Expression of Nanog gene promotes NIH3T3 cell proliferation. | 1.01e-07 | 3 | 163 | 3 | 16259959 | |
| Pubmed | 1.01e-07 | 3 | 163 | 3 | 12609610 | ||
| Pubmed | 1.01e-07 | 3 | 163 | 3 | 24227785 | ||
| Pubmed | The pluripotency factor nanog promotes breast cancer tumorigenesis and metastasis. | 1.01e-07 | 3 | 163 | 3 | 23770853 | |
| Pubmed | Nanog-independent reprogramming to iPSCs with canonical factors. | 1.01e-07 | 3 | 163 | 3 | 24527385 | |
| Pubmed | 1.01e-07 | 3 | 163 | 3 | 18086680 | ||
| Pubmed | 1.01e-07 | 3 | 163 | 3 | 18326714 | ||
| Pubmed | 1.01e-07 | 3 | 163 | 3 | 17215105 | ||
| Pubmed | 1.01e-07 | 3 | 163 | 3 | 17204467 | ||
| Pubmed | 1.01e-07 | 3 | 163 | 3 | 23200040 | ||
| Pubmed | NANOG alone induces germ cells in primed epiblast in vitro by activation of enhancers. | 1.01e-07 | 3 | 163 | 3 | 26751055 | |
| Pubmed | Epigenetic regulation of Nanog gene in embryonic stem and trophoblast stem cells. | 1.01e-07 | 3 | 163 | 3 | 17352742 | |
| Pubmed | 1.01e-07 | 3 | 163 | 3 | 23178592 | ||
| Pubmed | Stochastic NANOG fluctuations allow mouse embryonic stem cells to explore pluripotency. | 1.01e-07 | 3 | 163 | 3 | 25005472 | |
| Pubmed | 1.01e-07 | 3 | 163 | 3 | 8843087 | ||
| Pubmed | 1.01e-07 | 3 | 163 | 3 | 16773043 | ||
| Pubmed | 1.01e-07 | 3 | 163 | 3 | 23071603 | ||
| Pubmed | 1.01e-07 | 3 | 163 | 3 | 21119109 | ||
| Pubmed | 1.01e-07 | 3 | 163 | 3 | 32145514 | ||
| Pubmed | Nanog safeguards pluripotency and mediates germline development. | 1.01e-07 | 3 | 163 | 3 | 18097409 | |
| Pubmed | Heterogeneities in Nanog Expression Drive Stable Commitment to Pluripotency in the Mouse Blastocyst. | 1.01e-07 | 3 | 163 | 3 | 25753417 | |
| Pubmed | 1.01e-07 | 3 | 163 | 3 | 17075569 | ||
| Pubmed | 1.01e-07 | 3 | 163 | 3 | 22337995 | ||
| Pubmed | 1.01e-07 | 3 | 163 | 3 | 18290762 | ||
| Pubmed | Reprogramming of mouse fibroblasts into induced pluripotent stem cells with Nanog. | 1.01e-07 | 3 | 163 | 3 | 23333380 | |
| Pubmed | 1.01e-07 | 3 | 163 | 3 | 25825768 | ||
| Pubmed | Epithelial cell senescence induces pulmonary fibrosis through Nanog-mediated fibroblast activation. | 1.01e-07 | 3 | 163 | 3 | 31891567 | |
| Pubmed | 1.01e-07 | 3 | 163 | 3 | 15592690 | ||
| Pubmed | Abnormal regulation of the sympathetic nervous system in alpha2A-adrenergic receptor knockout mice. | 1.01e-07 | 3 | 163 | 3 | 10385696 | |
| Pubmed | Isolation and characterization of the murine Nanog gene promoter. | 1.01e-07 | 3 | 163 | 3 | 15916719 | |
| Pubmed | Nanog retrotransposed genes with functionally conserved open reading frames. | 1.01e-07 | 3 | 163 | 3 | 16845474 | |
| Pubmed | 1.01e-07 | 3 | 163 | 3 | 16313224 | ||
| Pubmed | Effect of Nanog overexpression on the metastatic potential of a mouse melanoma cell line B16-BL6. | 1.01e-07 | 3 | 163 | 3 | 33665763 | |
| Pubmed | 1.01e-07 | 3 | 163 | 3 | 22560155 | ||
| Pubmed | 1.01e-07 | 3 | 163 | 3 | 22028025 | ||
| Pubmed | Context-Dependent Functions of NANOG Phosphorylation in Pluripotency and Reprogramming. | 1.01e-07 | 3 | 163 | 3 | 28457890 | |
| Pubmed | Two functionally distinct alpha2-adrenergic receptors regulate sympathetic neurotransmission. | 1.01e-07 | 3 | 163 | 3 | 10647009 | |
| Pubmed | Requirement of Nanog dimerization for stem cell self-renewal and pluripotency. | 1.01e-07 | 3 | 163 | 3 | 18436640 | |
| Pubmed | 1.01e-07 | 3 | 163 | 3 | 21499299 | ||
| Pubmed | Phosphorylation of NANOG by casein kinase I regulates embryonic stem cell self-renewal. | 1.01e-07 | 3 | 163 | 3 | 33107035 | |
| Pubmed | 1.01e-07 | 3 | 163 | 3 | 35976266 | ||
| Pubmed | 1.01e-07 | 3 | 163 | 3 | 11181434 | ||
| Pubmed | 1.01e-07 | 3 | 163 | 3 | 24681518 | ||
| Pubmed | 1.01e-07 | 3 | 163 | 3 | 20692245 | ||
| Cytoband | 1p36.13 | 4.76e-05 | 56 | 162 | 4 | 1p36.13 | |
| GeneFamily | Immunoglobulin like domain containing | CEACAM5 SEMA7A VSIG4 CEACAM6 CSF1R FCGR3A FCGR3B CEACAM16 CNTN3 KIRREL1 IGSF3 | 8.58e-09 | 193 | 99 | 11 | 594 |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | MPL CEACAM5 SEMA7A CEACAM6 CR1 TFRC SIRPG CSF1R FCGR3A CLEC4D FCGR3B TSPAN7 CD68 | 2.33e-07 | 394 | 99 | 13 | 471 |
| GeneFamily | Adenosine receptors|V-set domain containing | SIGLEC12 CEACAM5 PSG2 PSG11 VSIG4 CEACAM6 SIRPG CEACAM16 IGSF3 | 2.73e-07 | 163 | 99 | 9 | 590 |
| GeneFamily | Adrenoceptors | 1.31e-05 | 9 | 99 | 3 | 169 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 2.67e-04 | 57 | 99 | 4 | 1179 | |
| GeneFamily | CD molecules|V-set domain containing|Immunoglobulin like domain containing|Carcinoembryonic antigen related cell adhesion molecule family | 2.96e-04 | 24 | 99 | 3 | 906 | |
| GeneFamily | Chitinases | 6.12e-04 | 7 | 99 | 2 | 816 | |
| GeneFamily | Transmembrane channel likes | 8.13e-04 | 8 | 99 | 2 | 1135 | |
| GeneFamily | CD molecules|V-set domain containing|Pregnancy specific glycoproteins | 1.58e-03 | 11 | 99 | 2 | 1315 | |
| GeneFamily | Cholinergic receptors nicotinic subunits | 3.39e-03 | 16 | 99 | 2 | 173 | |
| GeneFamily | NKL subclass homeoboxes and pseudogenes | 5.92e-03 | 67 | 99 | 3 | 519 | |
| Coexpression | LIAN_LIPA_TARGETS_6M | 6.07e-09 | 97 | 154 | 9 | MM1016 | |
| Coexpression | HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_7YR_DN | SIGLEC12 MGAM ITGA11 NOG MAN2B1 AVPR2 ADAM15 VSIG4 CR1 PKDREJ TFRC SIRPG KLHL3 CSF1R DPEP2 TSPAN7 TMC8 | 1.81e-06 | 740 | 154 | 17 | M41202 |
| Coexpression | LIAN_LIPA_TARGETS_6M | 9.04e-06 | 82 | 154 | 6 | M4345 | |
| Coexpression | CAIRO_LIVER_DEVELOPMENT_DN | 1.26e-05 | 239 | 154 | 9 | MM1274 | |
| Coexpression | TESAR_ALK_AND_JAK_TARGETS_MOUSE_ES_D4_DN | 2.32e-05 | 10 | 154 | 3 | MM741 | |
| Coexpression | GIBBONS_GENETIC_MOUSE_MODEL_LUNG_ADENOCARCINOMA_DOWN_IN_METASTASIS | 3.63e-05 | 32 | 154 | 4 | MM2 | |
| Coexpression | GSE3720_LPS_VS_PMA_STIM_VD2_GAMMADELTA_TCELL_DN | 3.79e-05 | 155 | 154 | 7 | M6347 | |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_DN | 4.46e-05 | 159 | 154 | 7 | MM760 | |
| Coexpression | OUYANG_PROSTATE_CANCER_MARKERS | 5.21e-05 | 35 | 154 | 4 | MM757 | |
| Coexpression | DESCARTES_FETAL_INTESTINE_MYELOID_CELLS | 6.77e-05 | 230 | 154 | 8 | M40210 | |
| Coexpression | MIKKELSEN_PLURIPOTENT_STATE_UP | 6.90e-05 | 14 | 154 | 3 | MM810 | |
| Coexpression | BYSTROEM_CORRELATED_WITH_IL5_DN | 8.13e-05 | 75 | 154 | 5 | MM605 | |
| ToppCell | Bronchial_Biopsy-Endothelial-Lymphatic|Endothelial / Tissue, Lineage and Cell class of Lung Cells from 10X | ATP8B3 CEACAM5 BCHE SSPOP PKHD1L1 PIEZO2 KBTBD11 NIPAL1 POLD4 | 6.89e-09 | 163 | 157 | 9 | 961c3a1303108afd680365466045f3460a30a7b0 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-08 | 184 | 157 | 9 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-08 | 184 | 157 | 9 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-08 | 184 | 157 | 9 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Myeloid-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.04e-08 | 157 | 157 | 8 | c8f516d3f5622202d3f8514f68614cd86ea3f667 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Myeloid|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.04e-08 | 157 | 157 | 8 | 4862a11ab8df27d26b4f1c1785e544a2d5b6db6e | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Myeloid-macrophage|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.04e-08 | 157 | 157 | 8 | a0ec1628ce29841889f1d9d4ee9422921af7b0b5 | |
| ToppCell | facs-Heart-LA-18m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-07 | 165 | 157 | 8 | be7e18d798e81e4b0f3080054aa222c6913e350b | |
| ToppCell | facs-Heart-LA-18m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-07 | 165 | 157 | 8 | 941a5b95164eaea47c3e6376e358f94c15b98312 | |
| ToppCell | droplet-Kidney-nan-24m-Myeloid-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-07 | 167 | 157 | 8 | 2ee1660be117e20f24557522345572d11cbee813 | |
| ToppCell | droplet-Fat-Scat-18m-Myeloid-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-07 | 168 | 157 | 8 | 749eccebe4ee066f827d2a3980512f195f23ac27 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Myeloid-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-07 | 169 | 157 | 8 | 0f5e737b265ba333275a0cd289dab029a1542075 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-07 | 169 | 157 | 8 | aec1b4c7e973a31c53aaea47c2c05d24ce16aa4f | |
| ToppCell | droplet-Spleen-nan-21m-Hematologic-proerythroblast|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-07 | 170 | 157 | 8 | 03cb4e508356f85372a588c8d1c6babf2a012683 | |
| ToppCell | droplet-Spleen-nan-21m-Hematologic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-07 | 171 | 157 | 8 | 9498c35b2a2c3a339dc8c5d49c8ec20d8ad52753 | |
| ToppCell | facs-Heart-RA-18m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-07 | 171 | 157 | 8 | 467f53033f172905e653d85aaa6751a00e5d9e10 | |
| ToppCell | facs-Heart-RA-18m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-07 | 171 | 157 | 8 | 15fedb078d93ac4b7fd2945870b50a718f665487 | |
| ToppCell | droplet-Spleen-nan-21m-Hematologic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-07 | 171 | 157 | 8 | db544252f98e073e5bb4bec4a110cd58e6434435 | |
| ToppCell | Bronchial_Biopsy-Endothelial-Lymphatic|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.82e-07 | 172 | 157 | 8 | c41f5a66781bbf63afce7ca5d118cc6d8e0fe0bc | |
| ToppCell | facs-Heart-RA-3m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-07 | 173 | 157 | 8 | 4fa5f502fa3ff8f888e279f68a0dafd91b37f26f | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Hematologic|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-07 | 173 | 157 | 8 | a0e4d25db186b9f7ff819abc0db68ad58c92ba3b | |
| ToppCell | facs-Heart-RA-3m-Myeloid|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-07 | 173 | 157 | 8 | 5058cb5e3f2d57dbe947e1b113eb2bef7bf6dd7d | |
| ToppCell | facs-Heart-RA-3m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-07 | 173 | 157 | 8 | ea406b47ff3ead992bc06f6b1707c76eee574782 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Hematologic-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-07 | 173 | 157 | 8 | 1ea8b8b89611bebf6acb700fb04a7d38720775a9 | |
| ToppCell | droplet-Liver-Npc-18m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-07 | 175 | 157 | 8 | 92a4a3fd323ee8360edd659f9e16dfddc8788e2f | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-07 | 182 | 157 | 8 | aab96e856bb4cb4418a97b7b1aa06505cafb317a | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.93e-07 | 183 | 157 | 8 | c12a4603cf81b5736553a4530cea5cefab80556f | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.05e-07 | 184 | 157 | 8 | 94139bc2c880db3a791741ff7c5630cca52263a5 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.60e-07 | 188 | 157 | 8 | 5f6ad5d693145d846ca561c2fa55465a88e40b90 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_I-D|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.06e-07 | 191 | 157 | 8 | 7d00796459f4ff0ab7f06a8379b2d34e76b078b2 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c4-CD14-CD16|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.39e-07 | 193 | 157 | 8 | f492ed02a46f3a45dc6005f9f18ab12a84bfa2a3 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.39e-07 | 193 | 157 | 8 | b52d5661edff83ac4c5fe2bf89d6672016bb827b | |
| ToppCell | Caecum-(4)_Monocyte|Caecum / shred on region, Cell_type, and subtype | 5.75e-07 | 200 | 157 | 8 | 6bfd6ab395e09087aeedc9a7c9ada1b4b8a26194 | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Monocytic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.75e-07 | 200 | 157 | 8 | 7076b0db66c8f90c8f9ccfbc8bc0dcc82b15e5f3 | |
| ToppCell | Caecum-Monocyte-Monocyte|Caecum / Region, Cell class and subclass | 5.75e-07 | 200 | 157 | 8 | d33619b6c721eae3ebe50fba6b9d31fa99f2248f | |
| ToppCell | Caecum-(4)_Monocyte-(40)_Monocyte|Caecum / shred on region, Cell_type, and subtype | 5.75e-07 | 200 | 157 | 8 | b078058efc51f0ff4d92123b712933b32824c655 | |
| ToppCell | Caecum-Monocyte|Caecum / Region, Cell class and subclass | 5.75e-07 | 200 | 157 | 8 | 9e8d38d024a315512521b349e8ac7caa56219daf | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.50e-07 | 145 | 157 | 7 | 4f8b188a93a038afbc7a446df8467ad544f5b1cb | |
| ToppCell | facs-Limb_Muscle-Muscle_forelimb_and_hindlimb-18m-Myeloid-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-06 | 157 | 157 | 7 | c3451b33780499fd62672e7cd71c7e8cb6ccc2c5 | |
| ToppCell | facs-Limb_Muscle-Muscle_forelimb_and_hindlimb-18m-Myeloid|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-06 | 157 | 157 | 7 | 92cd58b62e46b93f90e05657fd201404ccae6ddb | |
| ToppCell | facs-Limb_Muscle-Muscle_forelimb_and_hindlimb-18m-Myeloid-macrophage|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-06 | 157 | 157 | 7 | 042129d1b514dc4ed8a5f45b52d9c73cf4807636 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-06 | 157 | 157 | 7 | 0966e347f8d32b13f8a3b3afba3f64637c69cdf9 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-06 | 157 | 157 | 7 | 6ebfedd91d62c6d4aa8f046657a899a279f82ba2 | |
| ToppCell | facs-Lung-Endomucin-24m-Myeloid|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-06 | 159 | 157 | 7 | 886cbaef39a3517514a3896b6b960d01a3af043d | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Myeloid-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.78e-06 | 162 | 157 | 7 | 4c6e0cadd0ff50b0f50e0cfdc9027210e72674b9 | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Myeloid-macrophage|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.78e-06 | 162 | 157 | 7 | 59147406c28b7cdf43a1815f99c15c2bd6ae8fa3 | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Myeloid|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.78e-06 | 162 | 157 | 7 | 8e0bcc23c3086fc4b0c9dbeec13a7edaf6b83750 | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Myeloid-macrophage|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.78e-06 | 162 | 157 | 7 | 736fdcbd0f7d50fc297f13d36ab4c0dc82ad509c | |
| ToppCell | facs-Heart-RA-18m-Myeloid|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-06 | 163 | 157 | 7 | da7ab9582e8070b07ca628a6394c86684d37d6ef | |
| ToppCell | facs-MAT-Fat-3m-Myeloid-myeloid_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-06 | 163 | 157 | 7 | 5fc836444bc156c8248abee001b0ecbe43f980c9 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Myeloid|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-06 | 164 | 157 | 7 | d6526551d0b183c3ef027ba3dbfddeac03fd93bb | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Myeloid-CD45____macrophage|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-06 | 164 | 157 | 7 | eba25e4d65ca66b5192a7a4d11423f3fa0956828 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Myeloid-macrophage|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-06 | 164 | 157 | 7 | e19fc6ba049336ab989a3a968bdbefd567971d73 | |
| ToppCell | facs-MAT-Fat-18m-Myeloid|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-06 | 166 | 157 | 7 | 9116be2805c34881debb999d8417e43832fcf2f2 | |
| ToppCell | droplet-Spleen-nan-18m-Hematologic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-06 | 166 | 157 | 7 | e841e62cb20235d6233f78f4155fb8c0ffb1ef1b | |
| ToppCell | facs-MAT-Fat-18m-Myeloid-nan|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-06 | 166 | 157 | 7 | 5c2667da79935f3d4b1edbfe7a10e7dbc2fa3ad0 | |
| ToppCell | droplet-Spleen-nan-18m-Hematologic-proerythroblast|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-06 | 166 | 157 | 7 | f751cbd01d4978ded7755874ab60504f6291afd7 | |
| ToppCell | droplet-Spleen-nan-18m-Hematologic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-06 | 166 | 157 | 7 | 3ca3ddb663644f0e7f70f9b75833bb54cd9191d3 | |
| ToppCell | facs-GAT-Fat-24m-Myeloid-myeloid_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.18e-06 | 167 | 157 | 7 | 5d9ffbcb539d9c50cef9dd792ea11aa37dd2c1df | |
| ToppCell | facs-GAT-Fat-24m-Myeloid|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.18e-06 | 167 | 157 | 7 | c31e41fb76ba261ac546fac3cc2b8337e39bfa86 | |
| ToppCell | facs-GAT-Fat-24m-Myeloid-nan|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.18e-06 | 167 | 157 | 7 | a04d1f2413fd24ad5e9cc67312220606157fecf3 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-06 | 168 | 157 | 7 | 95416f352801ce42cc317565e7dfb00478c593e1 | |
| ToppCell | droplet-Heart-nan-24m-Hematologic-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-06 | 168 | 157 | 7 | 0ef2d8dbcccc812dd0d99769048b95cf06faf023 | |
| ToppCell | droplet-Heart-nan-24m-Hematologic|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-06 | 168 | 157 | 7 | 0d505ddda32141b81173daecad11ca6b091688a9 | |
| ToppCell | droplet-Heart-nan-24m-Hematologic-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.36e-06 | 169 | 157 | 7 | 018f82b3271f90e29c29e2d733d5ced6919fc42e | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Myeloid-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.36e-06 | 169 | 157 | 7 | 2d3618f78484bd3508b7bdae3a0d0183cdae5057 | |
| ToppCell | droplet-Spleen-nan-3m-Hematologic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.36e-06 | 169 | 157 | 7 | 972618e684321060c7af2429f853a6d639e8aae8 | |
| ToppCell | droplet-Spleen-nan-3m-Hematologic-proerythroblast|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.36e-06 | 169 | 157 | 7 | 91cfff1ad559cc327c6bb71c98aa29f0b3642568 | |
| ToppCell | droplet-Spleen-nan-3m-Hematologic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.36e-06 | 169 | 157 | 7 | 8e5e513090e86ca29fb61dfd388014774c506914 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.46e-06 | 170 | 157 | 7 | f08aa6168ff0c20b2083dbf588dd3294e3d9580e | |
| ToppCell | droplet-Trachea-3m-Hematologic-myeloid-granulocyte-|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.56e-06 | 171 | 157 | 7 | 41932c9e70829ee3d55ca5fdb74d290fc8229416 | |
| ToppCell | droplet-Heart-4Chambers-18m-Hematologic-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.56e-06 | 171 | 157 | 7 | 4935a95d11ac997d183fab32cbaad837bf0a512b | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Hematologic-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-06 | 172 | 157 | 7 | dd2ab9a5652dc152841d73e25a9e7c40a8faa2a5 | |
| ToppCell | facs-BAT-Fat-18m-Myeloid-nan|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-06 | 172 | 157 | 7 | 36fe66a8c0aecee7a19269be23210c0ed7abb155 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Hematologic-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-06 | 172 | 157 | 7 | ce0c63fa83d68621445ba3e4d23c8a5e1a4db95e | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Hematologic-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-06 | 173 | 157 | 7 | 9b957dd442f3af0e5fb99f3c93606308a459d485 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.87e-06 | 174 | 157 | 7 | b487c5c46f074a69b9526a2c72daf218f66aa44b | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Myeloid-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.87e-06 | 174 | 157 | 7 | 3533a47885af453d97739e5576e989d93d31be32 | |
| ToppCell | droplet-Thymus-nan-24m-Myeloid-Macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.87e-06 | 174 | 157 | 7 | 44c21521991ad4789783d73d5aa4993a22876886 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.87e-06 | 174 | 157 | 7 | dc4298c1d9359f7e37454e9451f889017227d5cf | |
| ToppCell | droplet-Liver-Npc-18m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.98e-06 | 175 | 157 | 7 | 1973fff0d7e1a94b31f461a39b91cc7984ebd8f1 | |
| ToppCell | droplet-Marrow-nan-24m-Myeloid-monocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.09e-06 | 176 | 157 | 7 | eddac2ba68d234e3f56f4ca0e11c19bc0e95b6e1 | |
| ToppCell | droplet-Liver-Npc-18m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.09e-06 | 176 | 157 | 7 | 1e430dffddd315d9a1cb4bd7fef5077656351c65 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.21e-06 | 177 | 157 | 7 | 382f0d6bbff01e84b0c7840e74ac865864e6da89 | |
| ToppCell | droplet-Spleen-nan-24m-Hematologic-proerythroblast|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-06 | 177 | 157 | 7 | 5f20a1a875d6f85ec07b097e6afdb07c2f8f88ff | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.33e-06 | 178 | 157 | 7 | 0b398656f26c4061b11ccf98908d0e2e1367585a | |
| ToppCell | droplet-Limb_Muscle-nan-18m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.59e-06 | 180 | 157 | 7 | d3d0be136fff5d3e39ecf5a5dbefc1d0d0a6c814 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-Myeloid-Macrophages|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.59e-06 | 180 | 157 | 7 | 7af90f0e7ca001bf1fe5c860ee54c4cc8eb483bf | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.72e-06 | 181 | 157 | 7 | a93df1ba23d5b5f249491d69d12bfc0e274dafcf | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Myeloid-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.72e-06 | 181 | 157 | 7 | 7b18372e8a8fcadb11393dd83fc3da607b98481f | |
| ToppCell | facs-Heart-RA|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.86e-06 | 182 | 157 | 7 | 8292e8e8474c930ffb88cbab4f6ebdb6f58db645 | |
| ToppCell | wk_08-11-Hematologic-Myeloid-APOE+_Mac2|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.30e-06 | 185 | 157 | 7 | 8f843badc0e26cb7300c83db56c7974beb90fcf3 | |
| ToppCell | 5'-Adult-Distal_Rectal-Epithelial-Tuft-related|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.45e-06 | 186 | 157 | 7 | 4046b701aa29712d9f7c774f8955215122c3c003 | |
| ToppCell | 368C-Myeloid-Macrophage-FABP4+_Macrophage_3|368C / Donor, Lineage, Cell class and subclass (all cells) | 4.45e-06 | 186 | 157 | 7 | ddfadd43efeac3b3e6b7062590cc2b8f2f2db2ab | |
| ToppCell | 5'-Adult-Distal_Rectal-Epithelial-Tuft-related-BEST4+_epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.45e-06 | 186 | 157 | 7 | bd5837033c1ffcbe5dd30195cc4846a2ba351bcd | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.61e-06 | 187 | 157 | 7 | 4e553721fa5598cb211f44e3226280b7e6885484 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.61e-06 | 187 | 157 | 7 | d36e7fc6125e7a4310499365022d38f34b757a73 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.61e-06 | 187 | 157 | 7 | 827eae63fabf6892a82ce7779b5f395958d3d628 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_macrophage-macrophage|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.78e-06 | 188 | 157 | 7 | 59d5c7b147af118442adadf708ce2d1422b1e9aa | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_macrophage|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.78e-06 | 188 | 157 | 7 | 2e268d8091e25d50bf05f26517d3ceb583801fd4 | |
| Drug | 4-nitro-phen-yl | 1.31e-08 | 93 | 153 | 9 | CID000119211 | |
| Drug | rhamnose | SIGLEC12 DPEP1 MGAM AMY2A CEACAM5 MAN2B1 ACR NAGLU BCHE PKDREJ FURIN LPO CNTN3 CTBS ADGRL3 | 1.92e-08 | 356 | 153 | 15 | CID000000840 |
| Drug | N-acetylhexosamine | DPEP1 MGAM ITGA11 AMY2A NOG MAN2B1 NAGLU BCHE CSF1R FCGR3A FCGR3B FURIN LPO CTBS DMP1 DNASE1 ADGRL3 | 2.10e-08 | 472 | 153 | 17 | CID000000899 |
| Drug | p-nitrophenyl | 5.66e-08 | 146 | 153 | 10 | CID000007416 | |
| Drug | Clonidine | 2.98e-07 | 3 | 153 | 3 | DB00575 | |
| Drug | Brimonidine | 2.98e-07 | 3 | 153 | 3 | DB00484 | |
| Drug | Tizanidine | 2.98e-07 | 3 | 153 | 3 | DB00697 | |
| Drug | Bethanidine | 1.18e-06 | 4 | 153 | 3 | DB00217 | |
| Drug | 2-methoxyidazoxan | 1.18e-06 | 4 | 153 | 3 | ctd:C058525 | |
| Drug | Sialic acids | ACP6 MGAM CEACAM5 MAN2B1 NAGLU APOB TFRC SIRPG COG1 LPO CTBS ADGRL3 | 2.43e-06 | 329 | 153 | 12 | CID000349960 |
| Drug | Fenoldopam | 2.95e-06 | 5 | 153 | 3 | DB00800 | |
| Drug | Sudan black B | 4.54e-06 | 64 | 153 | 6 | CID000061336 | |
| Drug | Phenoxybenzamine | 5.86e-06 | 6 | 153 | 3 | DB00925 | |
| Drug | Xylometazoline | 5.86e-06 | 6 | 153 | 3 | DB06694 | |
| Drug | Betulinic acid [472-15-1]; Up 200; 8.8uM; PC3; HT_HG-U133A | 8.04e-06 | 198 | 153 | 9 | 4101_UP | |
| Drug | alpha-naphthyl butyrate | 9.05e-06 | 72 | 153 | 6 | CID000076571 | |
| Drug | xylometazoline | 1.02e-05 | 7 | 153 | 3 | ctd:C009695 | |
| Drug | BG5P | 1.02e-05 | 7 | 153 | 3 | CID003082752 | |
| Drug | periodic acid | 1.06e-05 | 205 | 153 | 9 | CID000065185 | |
| Drug | Sudan III | 1.44e-05 | 78 | 153 | 6 | CID005809667 | |
| Drug | iodide | MPL CEACAM5 CEACAM6 APOB F12 PTH2R CRHR2 TFRC FCGR3A FCGR3B LPO LRP2 CD68 CNTN3 | 1.56e-05 | 534 | 153 | 14 | CID000024841 |
| Drug | Oxymetazoline | 1.63e-05 | 8 | 153 | 3 | ctd:D010109 | |
| Drug | Man(9)GlcNAc | 2.35e-05 | 51 | 153 | 5 | CID003081561 | |
| Drug | p-menthane | 2.43e-05 | 9 | 153 | 3 | CID000007459 | |
| Drug | Norepinephrine | 3.45e-05 | 10 | 153 | 3 | DB00368 | |
| Drug | Methamphetamine | 3.45e-05 | 10 | 153 | 3 | DB01577 | |
| Drug | Yohimbine | 3.45e-05 | 10 | 153 | 3 | DB01392 | |
| Drug | Glc)4 | 3.45e-05 | 10 | 153 | 3 | CID000189098 | |
| Drug | Droxidopa | 3.45e-05 | 10 | 153 | 3 | DB06262 | |
| Drug | Ro 20-0083 | 3.45e-05 | 10 | 153 | 3 | CID003082332 | |
| Drug | AC1L3M0Q | 3.45e-05 | 10 | 153 | 3 | CID000118008 | |
| Drug | benzyl-EDTA | 3.45e-05 | 10 | 153 | 3 | CID000129213 | |
| Drug | Napamezol | 4.49e-05 | 2 | 153 | 2 | CID000124655 | |
| Drug | Wy 27127 | 4.49e-05 | 2 | 153 | 2 | CID000125697 | |
| Drug | FG5P | 4.72e-05 | 11 | 153 | 3 | CID000127486 | |
| Drug | CNP-G5 | 4.72e-05 | 11 | 153 | 3 | CID000127309 | |
| Drug | AC1L201C | 4.72e-05 | 11 | 153 | 3 | CID000012643 | |
| Drug | 2C KM | 4.72e-05 | 11 | 153 | 3 | CID009549196 | |
| Drug | oleth-3-phosphate | 5.20e-05 | 60 | 153 | 5 | CID000021452 | |
| Drug | 17-AAG; Down 200; 0.1uM; MCF7; HG-U133A | 5.99e-05 | 198 | 153 | 8 | 221_DN | |
| Drug | Folin Marenzi reagent | 6.09e-05 | 32 | 153 | 4 | CID000452313 | |
| Drug | AC1L1I1P | 6.10e-05 | 62 | 153 | 5 | CID000004385 | |
| Drug | fluorescein isothiocyanate | 6.26e-05 | 147 | 153 | 7 | CID000018730 | |
| Drug | Ephedra | 6.26e-05 | 12 | 153 | 3 | DB01363 | |
| Drug | R625 | 6.89e-05 | 33 | 153 | 4 | CID000072375 | |
| Drug | methyl 1'-epiacarviosin | 8.10e-05 | 13 | 153 | 3 | CID000197426 | |
| Drug | isoacarbose | 8.10e-05 | 13 | 153 | 3 | CID000449165 | |
| Drug | S-isopropylisothiourea | 8.10e-05 | 13 | 153 | 3 | CID000445319 | |
| Drug | Lisuride | 1.03e-04 | 14 | 153 | 3 | DB00589 | |
| Drug | Pramipexole | 1.03e-04 | 14 | 153 | 3 | DB00413 | |
| Drug | Ropinirole | 1.03e-04 | 14 | 153 | 3 | DB00268 | |
| Drug | Cyclodextrins | 1.03e-04 | 14 | 153 | 3 | CID000024238 | |
| Drug | 2-chloro-4-nitrophenol | 1.03e-04 | 14 | 153 | 3 | CID000012074 | |
| Drug | Risperidone | 1.03e-04 | 14 | 153 | 3 | DB00734 | |
| Drug | BCDs | 1.09e-04 | 37 | 153 | 4 | CID000364214 | |
| Drug | 2-cyanoacetamide | 1.15e-04 | 162 | 153 | 7 | CID000007898 | |
| Drug | NSC406942 | MGAM AMY2A AMY2B MAN2B1 RTTN BCHE APOB TFRC MTIF2 SYNGR2 LPO YME1L1 DNASE1 | 1.19e-04 | 565 | 153 | 13 | CID000001115 |
| Drug | II-2 | 1.21e-04 | 38 | 153 | 4 | CID003050375 | |
| Drug | type-IV | 1.24e-04 | 281 | 153 | 9 | CID000000906 | |
| Drug | Cabergoline | 1.28e-04 | 15 | 153 | 3 | DB00248 | |
| Drug | Apomorphine | 1.28e-04 | 15 | 153 | 3 | DB00714 | |
| Drug | 4-nitrophenylmaltoheptaoside | 1.28e-04 | 15 | 153 | 3 | CID000173254 | |
| Drug | AC1OAGYH | 1.28e-04 | 15 | 153 | 3 | CID006857622 | |
| Drug | CGS 19281A | 1.34e-04 | 3 | 153 | 2 | CID000169339 | |
| Drug | dcaB | 1.34e-04 | 3 | 153 | 2 | CID000015340 | |
| Drug | opposide | 1.34e-04 | 3 | 153 | 2 | CID000209734 | |
| Drug | Bindschedler's Green | 1.34e-04 | 3 | 153 | 2 | CID000069473 | |
| Drug | CNP-NAG | 1.34e-04 | 3 | 153 | 2 | CID000128421 | |
| Drug | DPEC | 1.34e-04 | 3 | 153 | 2 | CID000129670 | |
| Drug | TBPM-PI | 1.34e-04 | 3 | 153 | 2 | CID009892071 | |
| Drug | ICI 106270 | 1.34e-04 | 3 | 153 | 2 | CID000128761 | |
| Drug | potassium tripolyphosphate | 1.34e-04 | 3 | 153 | 2 | CID000061695 | |
| Drug | AC1NB2KI | 1.34e-04 | 3 | 153 | 2 | CID004436564 | |
| Drug | RISUG | 1.34e-04 | 3 | 153 | 2 | CID000062707 | |
| Drug | phenyl -maltoside | 1.34e-04 | 3 | 153 | 2 | CID003081956 | |
| Drug | deamino-NADP | 1.34e-04 | 39 | 153 | 4 | CID000004482 | |
| Drug | Bay e 4609 | 1.56e-04 | 16 | 153 | 3 | CID003085308 | |
| Drug | naphthol-AS-acetate | 1.56e-04 | 16 | 153 | 3 | CID000096045 | |
| Drug | AC1L8TZY | 1.61e-04 | 76 | 153 | 5 | CID000408095 | |
| Drug | hydroxyvaline | 1.80e-04 | 42 | 153 | 4 | CID000095562 | |
| Drug | TPPS4 | 1.89e-04 | 17 | 153 | 3 | CID000049561 | |
| Drug | Paliperidone | 1.89e-04 | 17 | 153 | 3 | DB01267 | |
| Drug | Pergolide | 1.89e-04 | 17 | 153 | 3 | DB01186 | |
| Drug | alinidine | 1.89e-04 | 17 | 153 | 3 | CID000036354 | |
| Drug | AC1L1IPV | 1.97e-04 | 43 | 153 | 4 | CID000004683 | |
| Drug | 4-nitrophenol | 1.99e-04 | 177 | 153 | 7 | CID000000980 | |
| Drug | Rgd Peptide | 2.20e-04 | 239 | 153 | 8 | CID000104802 | |
| Drug | Bromocriptine | 2.25e-04 | 18 | 153 | 3 | DB01200 | |
| Drug | trimitan | 2.25e-04 | 18 | 153 | 3 | CID000005561 | |
| Drug | triphenyl phosphate | 2.25e-04 | 18 | 153 | 3 | CID000008289 | |
| Drug | 2cgx | 2.25e-04 | 18 | 153 | 3 | CID001548380 | |
| Drug | aprophen | 2.25e-04 | 18 | 153 | 3 | CID000071128 | |
| Drug | AM-m | 2.36e-04 | 45 | 153 | 4 | CID005494407 | |
| Drug | NH4Cl | 2.52e-04 | 184 | 153 | 7 | CID000025517 | |
| Drug | CD 86022 | 2.66e-04 | 19 | 153 | 3 | CID000122617 | |
| Drug | Methotrimeprazine | 2.66e-04 | 19 | 153 | 3 | DB01403 | |
| Drug | A-FN | 2.66e-04 | 19 | 153 | 3 | CID005287635 | |
| Drug | naphthol AS | 2.66e-04 | 19 | 153 | 3 | CID000066719 | |
| Drug | Vd 2 | 2.66e-04 | 19 | 153 | 3 | CID005289548 | |
| Drug | Dipivefrin | 2.67e-04 | 4 | 153 | 2 | DB00449 | |
| Disease | colon cancer (implicated_via_orthology) | 2.23e-05 | 11 | 154 | 3 | DOID:219 (implicated_via_orthology) | |
| Disease | level of low affinity immunoglobulin gamma Fc region receptor III-A in blood serum | 2.71e-05 | 2 | 154 | 2 | OBA_2040305 | |
| Disease | Lupus Vasculitis, Central Nervous System | 8.09e-05 | 3 | 154 | 2 | C0752332 | |
| Disease | Lupus Meningoencephalitis | 8.09e-05 | 3 | 154 | 2 | C0752334 | |
| Disease | Neuropsychiatric Systemic Lupus Erythematosus | 8.09e-05 | 3 | 154 | 2 | C0752335 | |
| Disease | Parkinson disease | 2.97e-04 | 321 | 154 | 8 | MONDO_0005180 | |
| Disease | cytosolic non-specific dipeptidase measurement | 4.00e-04 | 6 | 154 | 2 | EFO_0020310 | |
| Disease | galectin-7 measurement | 4.00e-04 | 6 | 154 | 2 | EFO_0022034 | |
| Disease | phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform measurement | 4.00e-04 | 6 | 154 | 2 | EFO_0020637 | |
| Disease | serine/threonine-protein kinase ULK3 measurement | 4.00e-04 | 6 | 154 | 2 | EFO_0803065 | |
| Disease | low affinity immunoglobulin gamma Fc region receptor II-a/b measurement | 5.59e-04 | 7 | 154 | 2 | EFO_0008211 | |
| Disease | ectonucleoside triphosphate diphosphohydrolase 3 measurement | 5.59e-04 | 7 | 154 | 2 | EFO_0020343 | |
| Disease | phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha measurement | 5.59e-04 | 7 | 154 | 2 | EFO_0801881 | |
| Disease | BCL-2-like protein 1 measurement | 5.59e-04 | 7 | 154 | 2 | EFO_0020177 | |
| Disease | uroplakin-3b-like protein measurement | 5.59e-04 | 7 | 154 | 2 | EFO_0802204 | |
| Disease | kinesin-like protein KIF16B measurement | 5.59e-04 | 7 | 154 | 2 | EFO_0801747 | |
| Disease | macrophage-stimulating protein receptor measurement | 5.59e-04 | 7 | 154 | 2 | EFO_0020550 | |
| Disease | tumor necrosis factor receptor superfamily member 3 measurement | 7.42e-04 | 8 | 154 | 2 | EFO_0020813 | |
| Disease | stabilin-2 measurement | 7.42e-04 | 8 | 154 | 2 | EFO_0020752 | |
| Disease | desmoglein-1 measurement | 7.42e-04 | 8 | 154 | 2 | EFO_0020321 | |
| Disease | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 measurement | 7.42e-04 | 8 | 154 | 2 | EFO_0801373 | |
| Disease | chromobox protein homolog 5 measurement | 7.42e-04 | 8 | 154 | 2 | EFO_0020258 | |
| Disease | kallikrein-6 measurement | 7.42e-04 | 8 | 154 | 2 | EFO_0801739 | |
| Disease | epididymal-specific lipocalin-10 measurement | 9.51e-04 | 9 | 154 | 2 | EFO_0801576 | |
| Disease | dickkopf-like protein 1 measurement | 9.51e-04 | 9 | 154 | 2 | EFO_0020324 | |
| Disease | cytochrome c oxidase subunit 4 isoform 2, mitochondrial measurement | 9.51e-04 | 9 | 154 | 2 | EFO_0801514 | |
| Disease | cyclin-dependent kinase 5:cyclin-dependent kinase 5 activator 1 complex measurement | 9.51e-04 | 9 | 154 | 2 | EFO_0020296 | |
| Disease | alpha-amylase 1 measurement | 9.51e-04 | 9 | 154 | 2 | EFO_0801371 | |
| Disease | oxysterols receptor LXR-beta measurement | 9.51e-04 | 9 | 154 | 2 | EFO_0801865 | |
| Disease | mast cell-expressed membrane protein 1 measurement | 9.51e-04 | 9 | 154 | 2 | EFO_0801787 | |
| Disease | plexin-B2 measurement | 9.51e-04 | 9 | 154 | 2 | EFO_0021867 | |
| Disease | interleukin-34 measurement | 9.51e-04 | 9 | 154 | 2 | EFO_0020505 | |
| Disease | leucine-rich repeat serine/threonine-protein kinase 2 measurement | 9.51e-04 | 9 | 154 | 2 | EFO_0021876 | |
| Disease | serine/threonine-protein kinase 16 measurement | 1.18e-03 | 10 | 154 | 2 | EFO_0020724 | |
| Disease | DNA-directed RNA polymerases I and III subunit RPAC1 measurement | 1.18e-03 | 10 | 154 | 2 | EFO_0801535 | |
| Disease | dipeptidase 2 measurement | 1.18e-03 | 10 | 154 | 2 | EFO_0801528 | |
| Disease | tropomyosin beta chain measurement | 1.18e-03 | 10 | 154 | 2 | EFO_0020787 | |
| Disease | interleukin-37 measurement | 1.18e-03 | 10 | 154 | 2 | EFO_0020506 | |
| Disease | insulin growth factor-like family member 3 measurement | 1.18e-03 | 10 | 154 | 2 | EFO_0801700 | |
| Disease | cytochrome p450 3a4 measurement | 1.44e-03 | 11 | 154 | 2 | EFO_0020303 | |
| Disease | peptidyl-glycine alpha-amidating monooxygenase measurement | 1.44e-03 | 11 | 154 | 2 | EFO_0801871 | |
| Disease | hyperhomocysteinemia (implicated_via_orthology) | 1.44e-03 | 11 | 154 | 2 | DOID:9279 (implicated_via_orthology) | |
| Disease | interleukin-10 receptor subunit alpha measurement | 1.44e-03 | 11 | 154 | 2 | EFO_0021890 | |
| Disease | guanylate-binding protein 6 measurement | 1.44e-03 | 11 | 154 | 2 | EFO_0801662 | |
| Disease | Hematologic Neoplasms | 1.73e-03 | 12 | 154 | 2 | C0376545 | |
| Disease | integral membrane protein 2B measurement | 1.73e-03 | 12 | 154 | 2 | EFO_0802634 | |
| Disease | oncostatin-M measurement | 1.73e-03 | 12 | 154 | 2 | EFO_0010792 | |
| Disease | tyrosine-protein kinase ZAP-70 measurement | 1.73e-03 | 12 | 154 | 2 | EFO_0020833 | |
| Disease | triglyceride measurement, alcohol consumption measurement | 1.97e-03 | 101 | 154 | 4 | EFO_0004530, EFO_0007878 | |
| Disease | Amyotrophic Lateral Sclerosis, Familial | 2.03e-03 | 48 | 154 | 3 | C4551993 | |
| Disease | Amyotrophic Lateral Sclerosis, Sporadic | 2.03e-03 | 48 | 154 | 3 | C1862941 | |
| Disease | kallikrein-12 measurement | 2.03e-03 | 13 | 154 | 2 | EFO_0008194 | |
| Disease | tRNA (guanine-N(7)-)-methyltransferase measurement | 2.03e-03 | 13 | 154 | 2 | EFO_0802162 | |
| Disease | AMYOTROPHIC LATERAL SCLEROSIS 1 | 2.28e-03 | 50 | 154 | 3 | C1862939 | |
| Disease | membranous glomerulonephritis (biomarker_via_orthology) | 2.36e-03 | 14 | 154 | 2 | DOID:10976 (biomarker_via_orthology) | |
| Disease | low affinity immunoglobulin gamma Fc region receptor III-B measurement | 2.36e-03 | 14 | 154 | 2 | EFO_0008212 | |
| Disease | 3-hydroxyphenylacetic acid measurement | 2.36e-03 | 14 | 154 | 2 | EFO_0010448 | |
| Disease | precuneus cortex volume measurement | 2.36e-03 | 14 | 154 | 2 | EFO_0010326 | |
| Disease | Intellectual Disability | 2.49e-03 | 447 | 154 | 8 | C3714756 | |
| Disease | Early Pregnancy Loss | 2.60e-03 | 109 | 154 | 4 | C3830362 | |
| Disease | Spontaneous abortion | 2.60e-03 | 109 | 154 | 4 | C0000786 | |
| Disease | Miscarriage | 2.60e-03 | 109 | 154 | 4 | C4552766 | |
| Disease | Abortion, Tubal | 2.60e-03 | 109 | 154 | 4 | C0000822 | |
| Disease | urate measurement | ATP8B3 C5orf67 ADAM15 DDR2 HECTD4 MALRD1 NSUN3 HOXD13 LRP2 NIPAL1 DMP1 DNASE1 | 2.65e-03 | 895 | 154 | 12 | EFO_0004531 |
| Disease | Hypertriglyceridemia | 2.72e-03 | 15 | 154 | 2 | C0020557 | |
| Disease | Myasthenic Syndromes, Congenital, Slow Channel | 3.10e-03 | 16 | 154 | 2 | C0751885 | |
| Disease | congenital myasthenic syndrome (implicated_via_orthology) | 3.10e-03 | 16 | 154 | 2 | DOID:3635 (implicated_via_orthology) | |
| Disease | gout, hyperuricemia | 3.10e-03 | 16 | 154 | 2 | EFO_0004274, EFO_0009104 | |
| Disease | Hypertensive disease | 3.28e-03 | 190 | 154 | 5 | C0020538 | |
| Disease | SLAM family member 7 measurement | 3.50e-03 | 17 | 154 | 2 | EFO_0008287 | |
| Disease | Inborn Errors of Metabolism | 3.50e-03 | 17 | 154 | 2 | C0025521 | |
| Disease | Dementia | 3.50e-03 | 17 | 154 | 2 | C0497327 | |
| Disease | Congenital Myasthenic Syndromes, Postsynaptic | 3.50e-03 | 17 | 154 | 2 | C0751883 | |
| Disease | low affinity immunoglobulin gamma Fc region receptor II-a measurement | 3.50e-03 | 17 | 154 | 2 | EFO_0021969 | |
| Disease | glycoprotein measurement | 3.56e-03 | 119 | 154 | 4 | EFO_0004555 | |
| Disease | Acute Myeloid Leukemia, M1 | 4.24e-03 | 125 | 154 | 4 | C0026998 | |
| Disease | Acute Myeloid Leukemia (AML-M2) | 4.24e-03 | 125 | 154 | 4 | C1879321 | |
| Disease | Congenital Myasthenic Syndromes, Presynaptic | 4.37e-03 | 19 | 154 | 2 | C0751884 | |
| Disease | sodium-coupled monocarboxylate transporter 1 measurement | 4.37e-03 | 19 | 154 | 2 | EFO_0802076 | |
| Disease | Obesity | 4.52e-03 | 205 | 154 | 5 | C0028754 | |
| Disease | serum carcinoembryonic antigen measurement | 4.83e-03 | 20 | 154 | 2 | EFO_0005760 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PALYWLSGLTCTEQN | 46 | P10768 | |
| QSGSFNAPWAVTSLY | 251 | P06276 | |
| ITGPWQEASNNYSCL | 891 | Q9Y6Y1 | |
| DWNTSDFCITPQIYN | 441 | O42043 | |
| IIDWTPQGQFYHNCS | 261 | Q9UKH3 | |
| DWNTSDFCITPQIYN | 551 | Q9UKH3 | |
| SFPNEYHNNADCTWT | 256 | Q7Z407 | |
| YGNNLNCIWTIISDP | 741 | Q7Z407 | |
| FYPNSLNCTWTVDVT | 1086 | Q7Z407 | |
| VYCNIPDATSWSFPN | 2311 | Q68DQ2 | |
| VQSLLYCNENGFWGT | 391 | O60477 | |
| YCNENGFWGTFLESQ | 396 | O60477 | |
| SYAQQCQSLWGPGAQ | 526 | Q13444 | |
| STQWYNGRVQPTNVC | 211 | P10323 | |
| SISVTYFPFDWQNCS | 151 | P07510 | |
| FFFWIGYCNSSLNPV | 421 | P18825 | |
| AGAYQCEVWNPVSVS | 196 | Q2WEN9 | |
| PAQYSWFVNGTFQQS | 266 | P06731 | |
| SAIVGPQNYGTFTCW | 316 | Q86SQ3 | |
| QSEENFNPNCSFWSY | 796 | Q9HAR2 | |
| CSIQVTYFPFDWQNC | 151 | P11230 | |
| FFWIGYCNSSLNPVI | 411 | P18089 | |
| QFDLAWQYGPCTGIT | 51 | Q9HCU8 | |
| CYFTNWSQDRQEPGK | 31 | Q15782 | |
| QVWFACYNGFTGQPL | 1011 | O60423 | |
| EWYQTCSNNGLVAGF | 101 | Q07507 | |
| YQCFQSTGWLGPVSI | 176 | O14678 | |
| ASSAPGYNWNQSVLF | 1211 | Q5TGY3 | |
| LLFTIGFCWAQYSPN | 6 | P19961 | |
| GFCWAQYSPNTQQGR | 11 | P19961 | |
| QYCNWRPDNLSQTSL | 91 | Q5VTE6 | |
| WSECIAAANAPYNQT | 216 | Q01459 | |
| TNEYLLWNPSTGQCY | 1221 | Q6DHV5 | |
| YTRTASFQGQPFIWC | 391 | P54802 | |
| LLFTIGFCWAQYSPN | 6 | P04746 | |
| GFCWAQYSPNTQQGR | 11 | P04746 | |
| TIGDYTWTNGSQPCV | 156 | P34810 | |
| SPSCWQYAVLLNRFN | 46 | Q9H649 | |
| GSWSYSQQQPQRVCS | 746 | Q9Y5H6 | |
| GLRCEWQNNYTQCAP | 1066 | Q8NEZ4 | |
| EQYNALSWLTCNPAT | 2171 | Q71F56 | |
| DGSYCQWPVSSEAQQ | 251 | Q6P1M3 | |
| AFYNCQLSWSSSPVV | 176 | Q969S2 | |
| GFSSAYPVWTAQLCA | 36 | P46199 | |
| VSYQAPNNTWLACTS | 376 | P61550 | |
| SVDINQCASGPGWYS | 276 | Q6PRD1 | |
| YNVSSHGCQLLPWTQ | 76 | Q2TV78 | |
| TLWETFTFCQEQPYS | 776 | Q16832 | |
| SISQFRNWYVDEPSC | 131 | Q6UX15 | |
| PAQYSWFINGTFQQS | 266 | P40199 | |
| WEASNSSGVPFCYFV | 1881 | O43451 | |
| CNWIVVNCSTPANYF | 811 | Q9ULD0 | |
| YNSWRAFCDLSQPQT | 566 | P22079 | |
| EATSYPNLCLQNSEW | 86 | Q6NT32 | |
| NGTWASKINYSQCEP | 86 | Q13324 | |
| WNSPFYNCGEESLQS | 236 | Q9H9S0 | |
| YIGSFWAQPLQNTDN | 256 | Q9H223 | |
| QFTCPSGRCIYQNWV | 226 | P98164 | |
| VPGNASSGWCIFIYN | 236 | Q15717 | |
| NTSCNIWGNSTEYRP | 1031 | Q9UKX5 | |
| CGVYTPQGFLDQWAS | 1011 | Q13219 | |
| WGLSCALPVTRYQNN | 11 | Q13316 | |
| TCSNDYIDQWCNPGN | 181 | Q9Y4D8 | |
| QVWCGSYRPEFAIQS | 721 | Q495T6 | |
| GNYVPNSWTQDNGCT | 266 | O00469 | |
| SQTGPGCILSFWFYN | 726 | Q5VYJ5 | |
| GNCAFVNPVYGNWSN | 2111 | Q5VYJ5 | |
| ECSWRTQSFNNYSPN | 236 | Q7Z6W7 | |
| FLTWNCDQSSISGPF | 101 | Q96EW2 | |
| QSWSVCKQVFPGLNY | 961 | P04114 | |
| AQAASWDQPQGCLTY | 56 | Q6ZP68 | |
| ASGYPQPNVTWLQCS | 421 | P07333 | |
| WCNVSGYQGPSEQNF | 41 | O75054 | |
| SPWTCYLSGHQPQNN | 101 | F2Z3F1 | |
| PSWYVQSFLFSLCQE | 741 | Q8WTW3 | |
| PSIYCTSNDDQVGIW | 211 | P17927 | |
| PSIYCTSNDDQVGIW | 661 | P17927 | |
| PSIYCTSNDDQVGIW | 1111 | P17927 | |
| DWNTSDFCITPQIYN | 441 | P61566 | |
| DWNTSDFCITPQIYN | 441 | P61567 | |
| FNAGCSYVRPSQWSS | 191 | P24855 | |
| TQFGNVPWYSEACSS | 321 | P09958 | |
| SASSPVNCQWDFYAP | 21 | P10643 | |
| PWQRCFQTTNGYLSD | 56 | Q96AQ9 | |
| QVYCTKDQPQGSHFW | 241 | P35453 | |
| NTDDGQQPFYCLTWT | 366 | Q5U5Z8 | |
| DWNTSDFCITPQIYN | 551 | P61565 | |
| QSSQQYQVTSCAWVP | 3561 | Q99698 | |
| KCQGAYSPEDNSTQW | 46 | O75015 | |
| QNFSAWCSQVVRLYP | 691 | O00754 | |
| TFDPTNQWLSCVYND | 351 | O60336 | |
| YDYCNSWSSPQLQSS | 101 | Q8NDX9 | |
| LVGAQFWSAYVPCQT | 126 | Q9H4A9 | |
| CSNEVFCYNPLTNIW | 371 | Q96G42 | |
| FQTHYNCTAWNSFGP | 466 | Q96J84 | |
| CLSTVEQYNPATNEW | 456 | Q9UH77 | |
| SLYRGCQQTCWEPTS | 51 | Q8IUC0 | |
| QYVLWASNISSPGCE | 386 | Q53GD3 | |
| WTYGSSLSNPLNCSV | 871 | Q9H583 | |
| DGKAYCFNPSLSTWN | 841 | P54198 | |
| YNVSSHGCQLLPWTQ | 71 | P26927 | |
| KCQGAYSPEDNSTQW | 46 | P08637 | |
| YPALVNCTTINWFSE | 2906 | Q9P225 | |
| VGGQFWSVYTPCDTQ | 76 | P16444 | |
| CFANSNPPAQYSWTI | 261 | Q9UQ72 | |
| PGNYPANTECTWTIN | 826 | Q9NQ36 | |
| AFCSFQIYAVPWQGT | 121 | P01034 | |
| VINPNRNWDTGTYQC | 86 | Q9P232 | |
| GYVLSLVCPNSSQAW | 16 | Q6NVV3 | |
| SASDFQFCWNQAPYA | 741 | Q5VVW2 | |
| PTTWGYNDNSCIFNI | 381 | Q5TDP6 | |
| TGDSGCWPHYSFQLQ | 276 | O15547 | |
| SQTFCPVLYAWNDLG | 151 | Q13253 | |
| LFCATNATWVPYTVQ | 2901 | Q6ZRI0 | |
| SWEYCDLAQCQTPTQ | 286 | P00748 | |
| PWASGENVYSYACQN | 191 | Q9BQQ7 | |
| VYTANFPNGCSSLCW | 1976 | Q86VV8 | |
| HTQSPQDQCWETYVG | 491 | Q7Z5M5 | |
| GQWYLPNATIQEDCN | 981 | A2VEC9 | |
| INPGNNDCWVSTGLY | 536 | A6NFQ2 | |
| TLNLYQQPSWIFCNG | 486 | Q8IVG5 | |
| GYQNSTRFWFPCVDS | 181 | Q6P1X5 | |
| WNSPFYNCGEESLQS | 236 | Q6NSW7 | |
| ADSPLQGLQFFWYCT | 366 | Q9NTG1 | |
| QGLQFFWYCTTDPRN | 371 | Q9NTG1 | |
| NQSTCTNYDTPLWLN | 116 | B4DS77 | |
| NNDGTYCANWTPGAI | 2406 | O75592 | |
| SQWEPVCGNNGITYL | 421 | G3V0H7 | |
| QYNALSWLTCDPATQ | 2136 | Q9UHV7 | |
| FPACSFNGTSAQEWF | 151 | Q9NUC0 | |
| FYPQSLQLTWSENGN | 276 | Q9P1W8 | |
| YPQCLWSSETFTGNG | 346 | A0A1B0GV85 | |
| PVTGQFLYQDSNWAS | 516 | P02786 | |
| SVLCSFSYPQNGWTA | 41 | Q96PQ1 | |
| QVFCYNPATDSWSAV | 381 | O94819 | |
| ATCFTLQSGNYWLEI | 456 | Q96N87 | |
| FFWFGYCNSSLNPVI | 426 | P08913 | |
| KSPCWYEEFSGQNTT | 196 | Q7LFX5 | |
| SQSLCPYDWIGFQNK | 31 | Q92478 | |
| FQSNCYFPLTDNKTW | 91 | Q8WXI8 | |
| NSQYRNWYTDEPSCG | 126 | Q9H9P2 | |
| NALAQRFQPYCDSWS | 386 | P24278 | |
| DCGLFTNYSAPWQVV | 561 | Q8IU68 | |
| DTGSSNLWVPSVYCQ | 91 | P20142 | |
| NLWVPSVYCQSQACT | 96 | P20142 | |
| WFRPADYNQCLQISN | 206 | P60508 | |
| LNAGYSNTATEWSQP | 841 | O75717 | |
| CTGDSWTQNTPNEYI | 726 | O94964 | |
| APGYNCSTWEKTFRQ | 91 | Q9H5I5 | |
| FPQLNELCNSWGTYF | 46 | Q6P2S7 | |
| SNPWNYSAVCVYSLG | 326 | O75326 | |
| LAIWCPGYSETQINA | 106 | Q969D9 | |
| ADSEVLYPNYQSCWS | 196 | Q9NPH0 | |
| VNCWFCNQDTLVPYG | 46 | Q5SNT2 | |
| CNQDTLVPYGNRNCW | 51 | Q5SNT2 | |
| NTTIPFSSCWANYTD | 4141 | Q86WI1 | |
| VGFCFLTNQWAVTNP | 121 | O43760 | |
| QHPSSWAAQETCYQL | 411 | P40238 | |
| YTCEVTWQTPDGNQV | 111 | Q9Y279 | |
| TLPGYVWSNSEQDCL | 491 | P49190 | |
| QACPNNEWSYQSETS | 536 | Q8TE23 | |
| QAWNSPFYNCGEESL | 161 | Q8N7R0 | |
| SICSDLQYWPVFIQS | 191 | Q96TA2 | |
| WQQNLYFNCSSPGVQ | 221 | Q9H1Z9 | |
| LVSWEDIQCTYGNPN | 341 | Q3LFD5 | |
| SQWENTEAPVSYKCN | 476 | Q969J2 | |
| YNPFDQGCASNWYLT | 236 | Q8WVZ1 | |
| NCQQLLATLWYDGFP | 306 | Q9UL62 | |
| LVSWEDIQCTYGNPN | 341 | Q9UMW8 | |
| CFANSNPPAQYSWTI | 261 | P11465 | |
| ITCSNPEQYVGWYSS | 81 | O15537 | |
| CGVQNYTNWSTSPYF | 151 | P41732 | |
| LNSCTNPWIYASFSS | 316 | P30518 | |
| AFSWQNPTIGYCQGL | 701 | Q9BYX2 | |
| PVEGWQCSLCTYINN | 621 | Q5FWF4 | |
| CQTSGWSLTEQDPYN | 351 | P22033 | |
| IYFNTWTTCQSIAFP | 176 | P60201 |